Researcher Profile and Settings

Researcher

• Name

  TOKUE Yutaka

Profile and Settings

• Name

  Tokue, Yutaka

Affiliation

• Gunma University, Associate Professor
• Gunma University, Associate Professor

Education

• 1985, Tohoku University, Faculty of Medicine, School of Medicine
• 1985, Tohoku University, Faculty of Medicine

Degree

• 条件付必須項目の入力がありません
• 条件付必須項目の入力がありません

Research Experience

• 1987, 1993
• 1993, 1997
• 1997, 2004, Tohoku University, Institute of Development, Aging and Cancer
• 1998, 2001
• 2004
• Gunma University, Associate Professor, Associate prof lecturer lv

Research Activities

Research Areas

• Infection Control
• Life sciences, Allergies and connective tissue disease

Research Interests

• Infection control
• Antimicrobial chemotherapy
• Respirology

Published Papers

• The Assessment of the Efficacy and Safety of Favipiravir for Patients with SARS-CoV-2 Infection: A Multicenter Non-randomized, Uncontrolled Single-arm Prospective Study., Yanagisawa K, Takara K, Suga H, Saito A, Hayashi T, Igarashi T, Tomizawa S, Saito E, Sumiyoshi H, Ohyama Y, Tokue Y, Nakamura T., Internal Medicine, Scientific journal
• The Assessment of the Efficacy and Safety of Favipiravir for Patients with SARS-CoV-2 Infection: A Multicenter Non-randomized, Uncontrolled Single-arm Prospective Study., Yanagisawa K, Takara K, Suga H, Saito A, Hayashi T, Igarashi T, Tomizawa S, Saito E, Sumiyoshi H, Ohyama Y, Tokue Y, Nakamura T., 2022, Internal Med, 9691, 9622, Scientific journal
• Serological screening of immunoglobulin G against SARS-CoV-2 nucleocapsid and spike protein before and after two vaccine doses among healthcare workers in Japan, Hiramoto S, Miyashita D, Kimura T, Niwa T, Uchida A, Sano M, Murata M, Nagasawa T, Tsunekawa K, Aoki T, Yoshida A, Kato T, Yanagisawa K, Tokue Y, Murakami M., May 2022, Tohoku J Exp Med.
• Efficacy and Safety of Favipiravirin Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial,, Shinkai M, Tsushima K, Tanaka S, Hagiwara E, Tarumoto N, Kawada I, Hirai Y, Fujiwara S, Komase Y, Saraya T, Koh H, Kagiyama N, Shimada M, Kanou D, Antoku S, Uchida Y, Tokue Y, Takamori M, Gon Y, Ie K,, Dec. 2021, Infectious Diseases and Therapy,, 10, 2489, 2509, Scientific journal
• Erythema nodosum-like eruption in coronavirus disease 2019: A case report and literature review of Asian countries., Kuriyama Y, Shimizu A, Oka H, Sato M, Makioka K, Ikota H, Yanagisawa K, Tokue Y, Tsukagoshi H, Motegi SI, 2021, J Dermatol., 48, 1588, 1592
• Comparison of 16S ribosomal RNA gene sequence analysis and conventional culture in the environmental survey of a hospital, Manaka A, Tokue Y, Murakami M, 2017, Journal of Pharmaceutical Health Care and Sciences

  DOI
• Improvement of severe COVID-19 in an elderly man by sequential use of antiviral drugs., Yatomi M, Takazawa T, Yanagisawa K, Kanamoto M, Matsui Y, Tukagoshi N, Saruki n, Saito S, Tokue Y, Maeno T, 2020, Case Reports in Infectious Diseases., Scientific journal
• Methicillin-resistant Staphylococcus aureus-induced right-sided infective endocarditis detected by transthoracic echocardiography: the importance of parasternal short-axis view screening., Morita K, Kato T, Kurosawa K, Yanagisawa K, Takuma N, Tokue Y, Murakami M., 2021, J Med Ultrason, Scientific journal
• Vaccination Status and Antibody Titers against Rubella and Measles among Japanese Female College Students Majoring in Childcare between 2015 and 2018., Shoho Y,Kimura T, Yanagawa Y, Saito A, Inoue T, Sudo C, Tsunekawa K, Araki O, Nara M, Tokue Y, Murakami M, 2018, Tohoku J. Exp. Med, 246, 73, 79, Scientific journal
• Mouse SWAM1 and SWAM2 are antibacterial proteins composed of a single whey acidic protein (WAP) motif, TOKUE YUTAKA / Hagiwara Koichi, 2003, J immunol
• Severe acute interstitial pneumonia and gefitinib, TOKUE YUTAKA / Inoue Akira, 2003, Lancet
• Isoleucyl-tRNA synthetase mutations in Staphylococcus aureus clinical isolates and in vitro selection of low-level mupirocin-resistant strains, TOKUE YUTAKA / Fujimura Shigeru, 2003, Antimicrob Agents Chemother
• Dendritic cells pulsed with live and dead Legionella pneumophila elicit distinct immune responses, TOKUE YUTAKA / Kikuchi Toshiaki, 2004, J Immunol
• Mannose-binding lectin gene polymorphism is a modulating factor in repeated respiratory infections, TOKUE YUTAKA / Gomi Kazunori, 2004, Chest
• Comparative in vitro activity of cabapenem antibiotics against respiratory pathogens isolated between 1999 and 2000, TOKUE YUTAKA / Watanabe Akira, 2001, J Infect Chemother
• Charithromycin suppresses lipopolysaccharide-induced interleukin -8 production by human monocytes through AP-1 and NF-kB transcription factors, TOKUE YUTAKA / kikuchi Toru, 2002, J Antimicrob Chemother
• Antibacterial activity of carbapenems against clinically isolated respiratory bacterial pathogens in Japan between 2003 and 2004, TOKUE YUTAKA / Watanabe Akira, 2005, Int J Antimicrob Agents
• Involvement of fractalkine/CX3CL1 expression by dendritic cells in the enhancement of host immunity against Legionella pneumophila., TOKUE YUTAKA / Kikuchi Toshiaki, 2005, Infect Immun
• Mouse and human cell activation by N-dodecanoyl DL-homoserine lactone, a Chromobacterium violacerum autoinducer. , Gomi K, Kikuchi T, Tokue Y, Fujimura S, Uehara A, Takada H, Watanabe A, Nukiwa T. , Dec. 2006, Infect Immun
• In vitro susceptibility of clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) to manufactured generic drugs compared with the brand vancomycin. , Fujimura S, Watanabe A, Fuse K, Kikuchi T, Gomi K, Tokue Y. , Apr. 2008, Int J Antimicrob Agents
• Characterization of resistance to VP-16 in human leukemic cell line, TOKUE YUTAKA / Saijo Y, 1989, Tohoku J Exp Med
• Increased levels of mitochondrial DNA in an etoposide-resistant human monocytic leukaemia cell line (THP-1/E), TOKUE YUTAKA / Saijo Yasuo, 1991, Eur J Cancer
• Detection of methicillin-resistant Staphylococcus aureus (MRSA) using polymerase chain reaction amplification, TOKUE YUTAKA / Shoji Satoru, 1991, Tohoku J Exp Med
• Comparison of a polymerase chain reaction assay and a conventional microbiologic method for detection of methicillin-resistant Staphylococcus aureus, TOKUE YUTAKA / Shoji Satoru, 1992, Antimicrob Agents Chemother
• Detecting methicillin resistance in Staphylococcus aureus by polymerase chain reaction-reply, TOKUE YUTAKA, 1992, Antimicrob Agents Chemother
• Tumor-associated fever in recurrent breast cancer with liver metastases, TOKUE YUTAKA / Zhang GJ, 1994, Breast Cancer
• Detection of novel mutations in the gyrA gene of Staphylococcus aureus by nonradioisotopic single-strand conformation polymorphism analysis and direct DNA sequencing., TOKUE YUTAKA / Sugano Kokichi, 1994, Antimicrob Agents Chemother
• Incidence of various gyrA mutations in 451 Staphylococcus aureus strains isolated in Japan and their susceptibilities to 10 fluoroquinolones., TOKUE YUTAKA / Takenouchi Takashi, 1995, Antimicrob Agents Chemother
• DNA gyrase gyrA gene mutations in ofloxacin-resistant Staphylococcus aureus, TOKUE YUTAKA / Sugano Kokichi, 1995, Int J Antimicrob Agents
• Identification of mycobacteria by nonradioisotopic single-strand conformation polymorphism analysis., TOKUE YUTAKA / Sugano Kokichi, 1995, Diagn Microbiol Infect Dis 
• Eyelid metastasis from breast cancer showing marked response to chemotherapy, TOKUE YUTAKA / Zhang GJ, 1995, Jpn J Clin Oncol
• Colonoscopy for frank bloody stools associated with cancer chemotherapy, TOKUE YUTAKA, 1997, Jpn J Clin Oncol 
• Characterization of gyrA, gyrB, grlA and grlB mutations in fluoroquinolone-resistant clinical isolates of Staphylococcus aureus, TOKUE YUTAKA / Takahashi Hiroshi, 1998, J Antimicrob Chemother
• A newly recognized acetylated metabolite of arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus, TOKUE YUTAKA / Fujimura Shigeru, 1998, J Antimicrob Chemother 
• Comparative in vitro activity of vancomycin and other antimicrobial agents against MRSA and Enterococcus faecium in Tohoku district of Japan, TOKUE YUTAKA / Lutffor AB, 1998, Chemotherapy 
• Specificity of 4'''-acetylation by an aminoglycoside-modifying enzyme in arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus, TOKUE YUTAKA / Fujimura Shigeru, 1998, Tohoku J Exp Med
• CD44 variant isoform expression and breast cancer prognosis, TOKUE YUTAKA / Mastumura Yasuhiro, 1998, Jpn  J Cancer Res
• Reduced topoisomerase 2-mediated DNA cleavage in VP-16 resistant human leukemic cell line, TOKUE YUTAKA / Saijo Yasuo, 1991, Anticancer Res
• Construction and Validation of a Practical Prognostic Index for Patients With Metastatic Breast Cancer, TOKUE YUTAKA / Yamamoto Noboru, 1998, J Clin Oncol
• A Phase I Trial of Docetaxel and 5-day continuous infusion of 5-Fluorouracil in Patients with Advanced or Recurrent Breast Cancer, TOKUE YUTAKA / Ando Masashi, 1998, Br J Cancer 
• In vitro activity of HSR-903, a new oral quinolone, against bacteria causing respiratory infections, TOKUE YUTAKA / Watanabe Akira, 1999, Antimicrob Agents Chemother 
• In vitro antimicrobial activity and penetration rate into sputum of gatifloxacin, a novel 6-fluoro-8-methoxy quinolone, and its therapeutic efficacy in respiratory infections, TOKUE YUTAKA / Watanabe Akira, 1999, J Infect Chemother
• Comparative in vitro activity of cabapenem antibiotics against respiratory pathogens isolated in recent years , TOKUE YUTAKA / Watanabe Akira, 1999, J Infect Chemother
• Comparative in vitro activity of S-4661, a new parenteral carbapenem, and other antimicrobial agents against respiratory pathogens, TOKUE YUTAKA / Watanabe Akira, 2000, Chemoterapy
• Novel arbekacin- and amikacin-modifying enzyme of methicillin-resistant Staphylococcus aureus, TOKUE YUTAKA / Fujimura Shigeru, 2000, FEMS microbiol Lett
• High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein acrA, TOKUE YUTAKA / Mazzariol A, 2000, Antimicrob Agents Chemother
• Association between Mycobacterial genotypes and disease progression in Mycobacterium avium pulmonary infection, Kikuchi T, Watanabe A, Gomi K, Sakakibara T, Nishimori K, Daito H, Fujimura S, Tazawa R, Inoue A, Ebina M, Tokue Y, Kaku M, Nukiwa T, 2009, Thorax
• Criteria for safety evaluation of antimicrobial agents, Watanabe A, Tokue Y, Aoki N, Matsumoto T, Yanagihara K, Higa F, Tsuge H, Nagashima M, Matsuoka H, Sasagawa Y, Matsumoto M, Fujimaki K, Taguchi K, Ariyasu M, Yamamoto N, Kunii O, Shiba K, Jan. 2011, J Infect Chemother
• Antibacterial activity of carbapenems against clinical isolates of respiratory bacterial pathogens in the northeastern region of Japan in 2007., Gomi K, Fujimura S, Fuse K, Takane H, Nakano Y, Kariya Y, Kikuchi T, Kurokawa I, Tokue Y, Watanabe A., Nov. 2011, J Infect Chemother
• Seroprevalence of Measles- and Mumps-Specific Immunoglobulin G among Japanese Healthcare Students Increased during 2007-2012, Kimura, Takao; Tsunekawa, Katsuhiko; Ogiwara, Takayuki; Tokue, Yutaka; Nara, Makoto; Inoue, Toshiya; Obuchi, Toshiko; Suto, Chiaki; Ohshima, Kihachi; Murakami, Masami, 2013, JAPANESE JOURNAL OF INFECTIOUS DISEASES
• Tuberculosis Screening Using a T-Cell Interferon-gamma Release Assay in Japanese Medical Students and Non-Japanese International Students, Ogiwara, Takayuki; Kimura, Takao; Tokue, Yutaka; Watanabe, Rumi; Nara, Makoto; Obuchi, Toshiko; Yaegashi, Akiko; Yomoda, Sachie; Ohshima, Kihachi; Murakami, Masami, 2013, TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE

  DOI
• ICDによるネットワークを軸にした地域の取り組み：群馬県, 徳江 豊, 2013, 22, 8, 772-775
• A Striking Increase in Seroprevalence of Measles-Specific Immunoglobulin G Among Native Japanese Healthcare Students: The Impact of a Five-Year Measles-Rubella Vaccination Catch-Up Campaign in Japan., Kimura T, Takeichi A, Inoue T, Suto C, Tsunekawa K, Nara M, Tokue Y, and Murakami M, 2015, Advances in Medicine and Biology
• JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy - The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG, Mikasa, Keiichi; Aoki, Nobuki; Aoki, Yosuke; Abe, Shuichi; Iwata, Satoshi; Ouchi, Kazunobu; Kasahara, Kei; Kadota, Junichi; Kishida, Naoki; Kobayashi, Osamu; Sakata, Hiroshi; Seki, Masahumi; Tsukada, Hiroki; Tokue, Yutaka; Nakamura-Uchiyama, Fukumi; Higa, Futoshi; Maeda, Koichi; Yanagihara, Katsunori; Yoshida, Koichiro, 2016, JOURNAL OF INFECTION AND CHEMOTHERAPY

  DOI
• Metallo-β-lactamase-producing Klebsiella pneumoniae infection in a non-hospital environment, Rumi Okazaki, Shuichi Hagiwara, Takao Kimura, Yutaka Tokue, Masahiko Kambe, Masato Murata, Makoto Aoki, Minoru Kaneko, Kiyohiro Oshima, Masami Murakami, 2016, Acute Medicine & Surgery

  DOI
• SUSCEPTIBILITIES OF Enterococcus faecium, PRSP AND MRSA TO RP59500 AND THEIR CORRELATIONS WITH THOSE TO OTHER DRUGS, INOUE Matsuhisa;SHIBA Kouya;SAKAMOTO Mitsuo;SAITO Akira;TOKUE Yutaka;SHIMIZU Yoshinori;YAMAGUCHI Keizo;MIYAZAKI Shuichi;WATANABE Akira;INAMATSU Takashi;KAWAI Tadashi;SHIMADA Jingoro;KAKU Mitsuo;HAYASHI Mutsumu;KUGA Akio;KANNO Harushige;ICHIYAMA Satoshi;KUBO Setsuko;AIHARA Masanori;UBUKATA Kimiko;HIGASHITSUTSUMI Minoru;SAKAMOTO Masako;IGARI Jun;KOHNO Shigeru;TOMONO Kazunori;OGURI Toyoko;HIRAKATA Yoichi;KOBAYASHI Yoshio;SAITO Atsushi;KUSANO Nobuchika;UEDA Yasushi, Apr. 1999, Jap J Antibiotics, 52, 4, 302, 312
• IN VITRO ACTIVITY OF BIAPENEM(BIPM) AGAINST CLINICALLY ISOLATED RESPIRATORY PATHOGENS IN 1996~1998, WATANABE Akira;TOKUE Yutaka;TAKAHASHI Hiroshi;KIKUCHI Toru;KOBAYASHI Takao;GOMI Kazunori;FUJIMURA Shigeru;YAYUI Satoko;NUKIWA Toshihiro;SHOJI Satoru;HONDA Yoshihiro, Dec. 1999, Jpn J Antibiot, 52, 12, 690, 694
• In vitro antimicrobial activity, penetration into sputum and therapeutic efficacy of grepafloxacin in respiratory tract infections, WATANABE Akira;KIKUCHI Hiroaki;SHOJI Satoru;TAKAHASHI Hiroshi;TOKUE Yutaka;MOTOMIYA Masakichi;NUKIWA Toshihiro;HONDA Yoshihiro;NAKAI Yushi;NIIZUMA Kazunao;TAKIZAWA Shigeo;YANASE Kenji;NAKAMURA Mikae, Jul. 1995, 43, 206, 216
• In vitro antimicrobial activity and therapeutic efficacy of cefluprenam in the treatment of respiratory tract infections, WATANABE Akira;TOKUE Yutaka;TAKAHASHI Hiroshi;SHOJI Satoru;KIKUCHI Hiroaki;MOTOMIYA Masakichi;NUKIWA Toshihiro;HONDA Yoshihiro;NAKAI Yushi;SATO Kazuo;NAGAI Kousaku;NAKAMURA Toshio, Nov. 1995, 43, 27, 33
• In vitro antimicrobial activity and penetration into sputum of balofloxacin, and its therapeutic efficacy in respiratory tract infections, WATANABE Akira;SHOJI Satoru;TAKAHASHI Hiroshi;KIKUCHI Hiroaki;TOKUE Yutaka;NUKIWA Toshihiro;MOTOMIYA Masakichi;HONMA Mitsunobu;KONNO Kiyoshi;SAYAMA Tsuneo;KASHIWAGI Makoto;ASO Noboru;NIIZUMA Kazunao;TAKIZAWA Shigeo;NAKAMURA Mikae, Nov. 1995, 43, 190, 201
• Double-blind study on grepafloxacin in pneumonia, KOBAYASHI Hiroyuki;TAKEDA Hiroaki;SAKAYORI Susumu;SAITO Akira;TOMIZAWA Masumi;HIRAGA Yohmei;OHMICHI Mitsuhide;TAKEBE Kazuo;MATSUKAWA Masakatsu;NAKAHATA Hisashi;OSONOI Takeshi;SAITO Miyoko;TAMURA Masashi;KONISHI Kazuki;OBARA Kazuo;YOSHIDA Masami;MOHRI Takashi;TAKEUCHI Kenichi;YOSHIDA Taiji;KOWATA Teruo;TANIFUJI Yukio;SHIRATO Kunio;TANNO Yasuo;HAYASHI Masato;SATO Koichi;TAKAHASHI Makoto;KUDO Kunio;ISHII Munehiko;SUGIYAMA Masaharu;ONO Yasuo;SHINDO Yuriko;HASHIGUCHI Ryoichi;YOSHINAGA Kaoru;WADA Tokuo;MATOBA Naoya;TOMINAGA Tadahiro;WATANABE Akira;NUKIWA Toshihiro;BABA Kenji;TOKUE Yutaka;NAKAI Hiroyuki;HONDA Yoshihiro;SATO Kazuo;NIIZUMA Kazunao;TAKIZAWA Shigeo;NAKAMURA Mikae;SAKAMOTO Masahiro;KATSU Masataka;OISHI Akira;SHIMADA Kaoru;KIKUCHI Norio;SAKAI Osamu;SHIBA Koya;TANIMOTO Shinichi;SAITO Atsushi;NAKATA Koichiro;NAKATANI Tatsuo;KUDO Koichiro;HORIUCHI Tadashi;SHISHIDO Harumi;NAGANO Hiroshi;TADA Hiroshi;CHYONABAYASHI Naohiko;NOGUCHI Hideyo;TANAKA Kazumasa;OTSUKA Hidehiko;MATSUMOTO Fumio;IMAI Takeo;OKUBO Takao;IKEDA Hirotada;MATSUMOTO Hiroshi;KANEKO Tamotsu;TANI Kenji;ARAKAWA Masaaki;WADA Koichi;IWATA Fumihide;HOSHINO Shigeyuki;TSUKADA Kiroki;KAWASHIMA Takashi;AOKI Nobuki;SEKINE Osamu;SUZUKI Yasutoshi;TAKEDA Hajimu;IZUMI Saburo;YOSHIMI Teruya;SATO Atuhiko;IWATA Masatoshi;TAKEUCHI Toshihiko;HANAKI Hidekazu;TAKEYAMA Shinji;KAWAKAMI Makoto;SHIMOKATA Kaoru;OGASAWARA Tomohiko;MOGI Hitoshi;SAKAI Shuzo;MINAMI Hironobu;SENDA Kazuyoshi;YAMAMOTO Masashi;NAGATAKE Masaaki;SUZUKI Shiro;TAGUCHI Osamu;IBATA Hidenori;SUMIDA Yasuhiro;MIKI Fumio;YANO Saburo;NAKAGAWA Masaru;SOEJIMA Rinzo;OKIMOTO Niro;NIKI Yoshihito;MATSUSHIMA Toshiharu;KIMURA Makoto;YAMAKIDO Michio;HASEGAWA Kenji;EGAWA Hiroya;YANAGIDA Jitsuro;WATANABE Kenichiro;ISHIBASHI Nobuzo;KURIMURA Osamu;NAKANO Kikuo;TAKEDA Koji;YOSHIDA Minoru;ARITOMI Takamichi;OIZUMI Kotaro;ICHIKAWA Yoichiro;TOKUNAGA Naoto;TANAKA Fumio;KAWAHARA Masao;SAISHO Masazumi;SHIGEMATSU Hiromichi;KAWAGUCHI Shinzo;FUKUDA Kenji;KATAOKA Hirofumi;MITSUTAKE Yoshiyuki;ISHIBASHI Tsuneo;TAKAMOTO Masashiro;KITAHARA Yoshinari;HARA Kohei;KOHNO Shigeru;KAKU Mitsuo;KOGA Hironobu;ITO Naomi;WATANABE Kiochi;KUSANO Shiro;SAKITO Osamu;MATSUMOTO Keizo;TAKASUGI Masakazu;NASU Masaru;GOTO Yoichiro;YAMASAKI Tohru;GOTO Jun;KITAGAWA Kazuo;SAITO Atsushi;FUKUHARA Hiroshi;INADOME Jun;NAKASHIMA Mitsuyoshi;DEGUCHI Koichi, Jun. 1997, 45, 6, 442, 462
• Double-blind study on grepafloxacin in chronic respiratory tract infection, KOBAYASHI Hiroyuki;TAKEDA Hiroaki;SAKAYORI Susumu;KAWAKAMI Yoshikazu;YAMAGUCHI Etsuro;SAITO Akira;TOMIZAWA Masumi;HIRAGA Yohmei;SHIRATO Kunio;TANNO Yasuo;WATANABE Akira;NUKIWA Toshihiro;BABA Kenji;TOKUE Yutaka;YAEGASHI Masahiro;NAKAI Hiroyuki;HONDA Yoshihiro;NIIZUMA Kazunao;TAKIZAWA Shigeo;SAKAMOTO Masahiro;KURIYAMA Takayuki;TATSUMI Koichiro;KATSU Masataka;OHISHI Akira;SHIMADA Kaoru;SANO Yasuyuki;MIYAMOTO Yasufumi;ARAI Yasuo;TANIMOTO Hiroichi;KOMATSUZAKI Katsumi;MORI Takeshi;KUDO Koichiro;HORUCHI Tadashi;SHISHIDO Harumi;WATANABE Hisashi;NAGANO Hiroshi;TADA Hiroshi;CHYONABAYASHI Naohiko;IRIMAJIRI Shoichiro;OBANA Mitsuo;NOGUCHI Hideyo;TANAKA Kazumasa;AKISAWA Takanori;OTSUKA Hidehiko;MATSUMOTO Fumio;IMAI Takeo;ODAGIRI Shigeki;SUZUKI Kaneo;TAKAHASHI Hiroshi;TAKAHASHI Kenichi;YOSHIIKE Yasuhiro;OGURA Takashi;HIRAI Yoshihiro;OKUBO Takao;KANEKO Tamotsu;TANI Kenji;ARAKAWA Masaaki;WADA Koichi;HOSHINO Shigeyuki;TSUDADA Hiroki;AOKI Nobuki;SEKINE Osamu;SUZUKI Yasutoshi;IZUMI Saburo;YOSHIMI Teruya;SATO Atsuhiko;CHIDA Kingo;SUDA Takafumi;TAMURA Ryoji;YOSHITOMI Atsushi;SUGANUMA Hideki;SHIMOKATA Kaoru;YAMAOTO Masashi;YAMORI Sadaaki;SHIBAGAKI Tomohisa;SATO Motohiko;YAMAMOTO Tomoko;SUZUKI Shiro;TAGUCHI Osamu;IBATA Hidenori;NARITA Nobuhiro;SAWAKI Masayoshi;MIKASA Keiichi;MIKI Fumio;YANO Saburo;NAKAGAWA Masaru;TSUBURA Eiro;MASUNO Fumiya;SASAKI Takao;MATSUMOTO Yukio;SOEJIMA Rinzo;OKIMOTO Niro;NIKI Yoshihito;YAMAKIDO Michio;HASEGAWA Kenji;KURIMURA Osamu;NAKANO Kikuo;TOMINAGA Naoko;OGURA Tsuyoshi;ASADA Kanji;AZUMA Masahiko;YAMAOTO Akihiko;HIWADA Kunio;KOHNO Nobuki;INOUE Giichi;YOSHIDA Minoru;ARITOMI Takamichi;OIZUMI Kotaro;ICHIKAWA Yoichiro;TOKUNAGA Naoto;KAWAHARA Masao;SAISHO Masazumi;SHIGEMATSU Hiromichi;ISHIBASHI Tsuneo;TAKAMOTO Masahiro;KITAHARA Yoshinari;HARA Kohei;KOHNO Mitsuo;KAKU Mitsuo;KOGA Hironobu;ITO Naomi;WATANABE Koichi;MATSUMOTO Keizo;TAKASUGI Masakazu;UTSUNOMIYA Yoshiaki;WATANABE Hiroshi;OMORI Akemi;TANAKA Hirofumi;TAKAHASHI Hidehiko;NASU Masaru;GOTO Yoichiro;YAMASAKI Tohru;GOTO Jun;KITAGAWA Kazuo;SHIMA Kiyoshi;TAKENAKA Shinobu;SAITO Atsushi;FUKUHARA Hiroshi;INADOME Jun;NAKASHIMA Mitsuyoshi;DEGUCHI Koichi, Jun. 1997, 45, 6, 463, 483
• Pulmonary infection due to Eikenella corrodens: Report of three cases, TAKAHASHI Hiroshi;KIKUCHI Toru;TOKUE Yutaka;KOBAYASHI Takao;SHOJI Satoru;HONDA Yoshihiro;CHIBA Junnichi;FUJIMURA Shigeru;NUKIWA Toshihiro;WATANABE Akira, Jul. 1998, 46, 7, 261, 265
• Rate of occurrence of mutations at Ser-84 in Staphylococcus aureus DNA gyrase A protein, TAKAHASHI Hirosi;SHOJI Satoru;KIKUCHI Hiroaki;WATANABE Akira;NUKIWA Toshihiro;HONDA Yoshihiro;TOKUE Yutaka, May 1995, 43, 5, 515, 519
• Changes in susceptibility of clinical isolates of Staphylococcus aureus to quinolones and other antibacterial agents from 1986 to 1993, TAKAHASHI Hirosi;SHOJI Satoru;KIKUCHI Hiroaki;WATANABE Akira;NUKIWA Toshihiro;HONDA Yoshihiro;TOKUE Yutaka, May 1995, 43, 5, 547, 550
• Inactivation of arbekacin by aminoglycoside-modifying enzymes from arbekacin-resistant strains of methicillin-resistant Stapyhlococcus aureus, FUJIMURA Shigeru;TOKUE Yutaka;TAKAHASHI Hiroshi;NUKIWA Toshihiro;WATANABE Akira, Jan. 1999, 47, 1, 1, 8
• In vitro antimicrobial activity of NM394, an active form of NM441, and therapeutic efficacy of NM441 in respiratory tract infections, WATANABE Akira;TAKAHASHI Hiroshi;KIKUCHI Hiroaki;TOKUE Yutaka;NUKIWA Toshihiro;MOTOMIYA Masakichi;NAKAGAWA Jun;HITOMI Hideaki;SATO Kazuo;KONNO Kiyoshi;SHOJI Satoru, Mar. 1996, 44, 249, 255
• Sepsis caused by methicillin-resistant Staphylococcus aureus (MRSA) without effects of vancomycin (VCM), teicoplanin (TEIC) and arbekacin (ABK) treated successfully and safely with intravenous administration of linezolid (LZD), OHKOUCHI Shinya;GOMI Kazunori;TOKUE Yutaka;KIKUCHI Toshiaki;FUJIMURA Shigeru;NUKIWA Toshihiro;WATANABE Akira, Dec. 2004, 52, 12, 787, 792
• 細菌性肺炎, TOKUE YUTAKA;WATANABE AKIRA, Jul. 1998, 25, 4, 417, 420
• Susceptibility to arbekacin of clinical strains of Pseudomonas aeruginosa isolated in the Tohoku area between 2003 and 2007, FUJIMURA Shigeru;GOMI Kazunori;TAKANE Hidenari;NAKANO Yoshihisa;FUSE Katsuhiro;KIKUCHI Toshiaki;TOKUE Yutaka;WATANABE Akira, Mar. 2009, 57, 2, 91, 96
• 社団法人 日本化学療法学会抗微生物薬安全性評価基準検討委員会 最終報告 : 抗微生物薬安全性評価基準, 渡辺 彰;徳江 豊;青木 信樹;松本 哲朗;柳原 克紀;比嘉 太;津下 宏之;長島 正人;松岡 ひろみ;笹川 裕次;松本 正人;藤巻 一雄;田口 賢治;有安 まり;山本 典史;國井 乙彦;柴 孝也, Mar. 2010, 58, 2, 141, 150
• 1. Urinary Antigen Test: Recent Advances and Future Perspectives., Tokue Yutaka, Nov. 2010, Nihon Naika Gakkai Zasshi, 99, 11, 2696, 2702
• 高齢者非小細胞肺癌に対するカルボプラチン,パクリタキセル(毎週投与)併用療法の第2相試験, 井上 彰;臼井 一裕;西條 康夫;前門戸 任;小犬丸 貞裕;田中 昌史;石本 修;松原 信行;大河内 庭也;木村 雄一郎;太田 洋充;徳江 豊;貫和 敏博, Oct. 2003, Japanese Journal of Lung Cancer, 43, 5
• 1. 胸部レ線上びまん性陰影を呈す肺疾患の診断 : TBLB の可能性(第 2 報)(第 15 回日本気管支学会東北支部会), 永井 宏美;河端 美則;西條 康夫;徳江 豊;穴沢 予識;三木 誠;本官 雅吉;玉橋 信彰;高橋 徹;荒井 秀夫, 1989, The Journal of the Japan Society for Respiratory Endoscopy, 11, 6
• 4 呼吸器感染症と自然免疫関連遺伝子多型(シンポジウム ゲノム情報と感染症(診断・治療・予防への応用),第580回新潟医学会), TOKUE Yutaka, Nov. 2004, Niigata medical journal, 118, 11, 589, 593
• 肺感染症1, 斎藤 厚;永田 忍彦;徳江 豊;増山 泰治;林 敏明;青島 正大, 1988, The Japanese journal of thoracic diseases, 26, 0, 181, 183
• 肺感染症10, 河野 茂;徳江 豊;山根 章;本田 芳宏;宮崎 義継;中川 勝;渋谷 泰寛, 1991, The Japanese journal of thoracic diseases, 29, 0, 430, 432
• Clinical Significance of Respiratory Infections Associated with Lung Cancer Patients., Watanabe Akira;Matsubara Nobuyuki;Nakai Yushi;Saito Jun-ichi;Honda Yoshihiro;Tokue Yutaka;Sugawara Shun-ichi;Numata Yuka;Kikuchi Toshiaki;Sato Joji, 1992, The Japanese journal of thoracic diseases, 30, 7, 1250, 1256
• IN VITRO ANTIMICROBIAL ACTIVITY OF CEFODIZIME (THR-221) AND CLINICAL EVALUATION IN RESPIRATORY TRACT INFECTIONS, AONUMA SEIICHI;NAGAI KOSAKU;TOKUE YUTAKA;KITAMURA NAOTO;HONDA YOSHIHIRO;ONO REIKO;WATANABE AKIRA;SASAKI MASAKO;OIZUMI KOTARO;KONNO KIYOSHI, 1988, CHEMOTHERAPY, 36, 5, 329, 338
• BASIC AND CLINICAL STUDIES ON CEFETAMET PIVOXIL AND ITS EFFICACY IN RESPIRATORY TRACT INFECTIONS, AONUMA SEIICHI;NAGAI KOSAKU;OIZUMI KOTARO;WATANABE AKIRA;HONDA YOSHIHIRO;TOKUE YUTAKA;KITAMURA NAOTO;SHOJI SATORU;MOTOMIYA MASAKICHI;KONNO KIYOSHI, 1990, CHEMOTHERAPY, 38, 1, 106, 109
• In vitro antimicrobial activity and therapeutic efficacy of SY5555 in respiratory tract infections, Watanabe Akira;Takeuchi Ken-ichi;Hirano Haruto;Arai Hideo;Matsuda Takashi;Honda Yoshihiro;Tokue Yutaka;Shoji Satoru;Takahashi Hiroshi;Kikuchi Hiroaki;Motomiya Masakichi;Nukiwa Toshihiro;Yoshida Tsukasa, 1994, CHEMOTHERAPY, 42, 1, 292, 298
• In vitro antimicrobial activity and therapeutic efficacy of cefluprenam in the treatment of respiratory tract infections, Watanabe Akira;Sato Kazuo;Nagai Kousaku;Nakamura Toshio;Tokue Yutaka;Takahashi Hiroshi;Shoji Satoru;Kikuchi Hiroaki;Motomiya Masakichi;Nukiwa Toshihiro;Honda Yoshihiro;Nakai Yushi, 1995, Japanese Journal of Chemotherapy, 43, 4, 27, 33
• SUSCEPTIBILITIES OF Enterococcus faecium, PRSP ANDMRSA TO RP59500 AND THEIR CORRELATIONS WITH THOSE TO OTHER DRUGS, INOUE MATSUHISA;IGARI JUN;OGURI TOYOKO;KOBAYASHI YOSHIO;SHIBA KOUYA;SAKAMOTO MITSUO;TOKUE YUTAKA;YAMAGUCHI KEIZO;MIYAZAKI SHUICHI;INAMATSU TAKASHI;SHIMADA JINGORO;SAITO AKIRA;KAKU MITSUO;KUGA AKIO;ICHIYAMA SATOSHI;AIHARA MASANORI;HIGASHITSUTSUMI MINORU;SAKAMOTO MASAKO;KOHNO SHIGERU;TOMONO KAZUNORI;HIRAKATA YOICHI;SAITO ATSUSHI;SHIMIZU YOSHINORI;KUSANO NOBUCHIKA;UEDA YASUSHI;WATANABE AKIRA;KAWAI TADASHI;HAYASHI MUTSUMU;KANNO HARUSHIGE;KUBO SETSUKO;UBUKATA KIMIKO, 1999, The Japanese Journal of Antibiotics, 52, 4, 302, 312
• LABORATORY STUDY OF NY-198 AND CLINICAL EVALUATION IN RESPIRATORY TRACT INFECTIONS, AONUMA SEIICHI;NAGAI KOHSAKU;TOKUE YUTAKA;KITAMURA NAOTO;HONDA YOSHIHIRO;ONO REIKO;WATANABE AKIRA;OHIZUMI KOHTARO;KONNO KIYOSHI, 1988, CHEMOTHERAPY, 36, 2, 486, 494
• TE-031 (A-56268) IN TREATMENT OF RESPIRATORY TRACT INFECTIONS, AONUMA SEIICHI;NAGAI KOSAKU;TOKUE YUTAKA;KITAMURA NAOTO;HONDA YOSHIHIRO;ONO REIKO;WATANABE AKIRA;SASAKI MASAKO;OIZUMI KOTARO;KONNO KIYOSHI, 1988, CHEMOTHERAPY, 36, 3, 549, 552
• THERAPEUTIC EFFICACY OF RU 28965 IN RESPIRATORY TRACT INFECTIONS, AONUMA SEIICHI;NAKAI YUSHI;SAITO JUNICHI;NAGAI KOSAKU;TOKUE YUTAKA;KITAMURA NAOTO;HONDA YOSHIHIRO;ONO REIKO;WATANABE AKIRA;SASAKI MASAKO;OIZUMI KOTARO;KONNO KIYOSHI, 1988, CHEMOTHERAPY, 36, 4, 245, 250
• THERAPEUTIC EFFICACY OF CEFOTIAM HEXETIL IN RESPIRATORY TRACT INFECTIONS, AONUMA SEIICHI;NAGAI KOSAKU;TOKUE YUTAKA;KITAMURA NAOTO;HONDA YOSHIHIRO;ONO REIKO;WATANABE AKIRA;SASAKI MASAKO;OIZUMI KOTARO;KONNO KIYOSHI, 1988, CHEMOTHERAPY, 36, 6, 246, 250
• IN VITRO ANTIMICROBIAL ACTIVITY OF SULBACTAM.AMPICILLIN AND ITS THERAPEUTIC EFFICACY IN LOWER RESPIRATORY INFECTIONS, WATANABE AKIRA;OHIZUMI KOHTARO;AONUMA SEIICHI;ONO REIKO;HONDA YOSHIHIRO;TOKUE YUTAKA;KONNO KIYOSHI, 1988, CHEMOTHERAPY, 36, 8, 108, 119
• LABORATORY STUDY OF T-3262, ITS SERUM AND SPUTUM LEVELS AND CLINICAL EVALUATION IN RESPIRATORY TRACT INFECTIONS, AONUMA SEIICHI;NAGAI KOSAKU;OIZUMI KOTARO;TOKUE YUTAKA;KITAMURA NAOTO;HONDA YOSHIHIRO;ONO REIKO;WATANABE AKIRA;SASAKI MASAKO;KONNO KIYOSHI, 1988, CHEMOTHERAPY, 36, 9, 374, 379
• Studies on multiple-resistant Staphylococcus aureus. (IV). Difference in incidence of methicillin-resistant Staphylococcus aureus (MRSA) among institutions, departments and specimens., WATANABE AKIRA;OHIZUMI KOHTARO;AONUMA SEIICHI;ONO REIKO;HONDA YOSHIHIRO;TOKUE YUTAKA;KITAMURA NAOTO;SHOJI SATORU;KONNO KIYOSHI, 1989, CHEMOTHERAPY, 37, 2, 125, 130
• Studies on multiple-resistant Staphylococcus aureus. (V). In vitro combined effect of cefuzonam plus minocycline against methicillin-resistant Staphylococcus aureus (MRSA)., WATANABE AKIRA;OHIZUMI KOHTARO;AONUMA SEIICHI;ONO REIKO;HONDA YOSHIHIRO;TOKUE YUTAKA;KITAMURA NAOTO;SHOJI SATORU;KONNO KIYOSHI, 1989, CHEMOTHERAPY, 37, 2, 131, 136
• IN VITRO ANTIMICROBIAL ACTIVITY OF 7432-S AND ITS THERAPEUTIC EFFICACY IN CHRONIC RESPIRATORY TRACT INFECTIONS, WATANABE AKIRA;OIZUMI KOTARO;AONUMA SEIICHI;ONO REIKO;HONDA YOSHIHIRO;TOKUE YUTAKA;KONNO KIYOSHI, 1989, CHEMOTHERAPY, 37, 1, 148, 157
• BASIC AND CLINICAL STUDIES ON CEFDINIR IN RESPIRATORY INFECTIONS, WATANABE AKIRA;NAKAI YUSHI;SAITO JUN-ICHI;NAKAI KOSAKU;OIZUMI KOTARO;AONUMA SEIICHI;ONO REIKO;HONDA YOSHIHIRO;TOKUE YUTAIKA;KITAMURA NAOTO;SHOJI SATORU;MOTOMIYA MASAKICHI, 1989, CHEMOTHERAPY, 37, 2, 312, 325
• Combinations of three antimicrobial agents(IV). The in vitro combined effect of three antimicrobial agents analyzed by the three-dimensional checkerboard method using a personal-computer system.:THE IN VITRO COMBINED EFFECT OF THREE ANTIMICROBIAL AGENTS ANALYZED BY THE THREE-DIMENSIONAL CHECKERBOARD METHOD USING A PERSONAL-COMPUTER SYSTEM, WATANABE AKIRA;KITAMURA NAOTO;OIZUMI KOTARO;HONDA YOSHIHIRO;ONO REIKO;TOKUE YUTAKA;SHOJI SATORU;MOTOMIYA MASAKICHI, 1990, CHEMOTHERAPY, 38, 4, 324, 329
• IN VITRO ANTIMICROBIAL ACTIVITY, PENETRATION INTO SPUTUM AND THERAPEUTIC EFFICACY OF FLEROXACIN IN RESPIRATORY INFECTIONS, WATANABE AKIRA;ARAI HIDEO;KONNO KIYOSHI;SHINDO SATOSHI;NAGAI KOSAKU;AONUMA SEIICHI;TOKUE YUTAKA;SHOJI SATORU;KITAMURA NAOTO;HONDA YOSHIHIRO;OIZUMI KOTARO;MOTOMIYA MASAKICHI;SHIMODA SHIGERU, 1990, CHEMOTHERAPY, 38, 2, 380, 389
• IN VITRO ANTIMICROBIAL ACTIVITY OF CEFPIROME AND ITS THERAPEUTIC EFFICACY IN RESPIRATORY INFECTIONS, WATANABE AKIRA;AONUMA SEIICHI;OIZUMI KOTARO;HONDA YOSHIHIRO;TOKUE YUTAKA;KITAMURA NAOTO;SHOJI SATORU;MOTOMIYA MASAKICHI, 1991, CHEMOTHERAPY, 39, 1, 124, 128
• IN VITRO ANTIMICROBIAL ACTIVITY OF CEFEPIME AND ITS THERAPEUTIC EFFICACY IN RESPIRATORY INFECTION, Watanabe Akira;Aonuma Seiichi;Oizumi Kotaro;Honda Yoshihiro;Tokue Yutaka;Kitamura Naoto;Shoji Satoru;Motomiya Masakichi, 1991, CHEMOTHERAPY, 39, 2, 132, 137
• IN VITROANTIMICROBIAL ACTIVITY OF PANIPENEM/BETAMIPRON AND ITS THRAPEUTIC EFFICACY IN RESPIRATORY INFECTIONS, Watanabe Akira;Aonuma Seiichi;Honda Yoshihiro;Tokue Yutaka;Kitamura Naoto;Shoji Satoru;Kikuchi Hiroaki;Motomiya Masakichi, 1991, CHEMOTHERAPY, 39, 3, 324, 332
• IN VITRO ANTIMICROBIAL ACTIVITY OF SPARFLOXACIN AND ITS THERAPEUTIC EFFICACY ON RESPIRATORY INFECTIONS, Watanabe Akira;Aonuma Seiichi;Kitamura Naoto;Shoji Satoru;Kikuchi Hiroaki;Tokue Yutaka;Honda Yoshihiro;Motomiya Masakichi, 1991, CHEMOTHERAPY, 39, 4, 219, 226
• IN VITRO ANTIMICROBIAL ACTIVITY OF MEROPENEM AND ITS THERAPEUTIC EFFICACY IN RESPIRATORY INFECTIONS, Honda Yoshihiro;Nagao Tukio;Shindo Satoshi;Saito Jun-ichi;Nakai Yushi;Arai Hideo;Anzai Yoshiyuki;Shoji Satoshi;Tokue Yutaka;Watanabe Akira;Motomiya Masakichi;Konno Kiyoshi;Hasuike Teruo;Sayama Tsuneo;Kanaya Tohru, 1992, CHEMOTHERAPY, 40, 1, 302, 311
• IN VITRO ANTIMICROBIAL ACTIVITY OF CEFCLIDIN AND ITS THERAPEUTIC EFFICACY IN RESPIRATORY INFECTIONS, Watanabe Akira;Aonuma Seiichi;Honda Yoshihiro;Tokue Yutaka;Kitamura Naoto;Shoji Satoru;Kikuchi Hiroaki;Motomiya Masakichi;Sato Kazuo, 1992, CHEMOTHERAPY, 40, 4, 267, 272
• In vitro antimicrobial activity, penetration into sputum and therapeutic efficacy of S-1108 in respiratory tract infections, Watanabe Akira;Shindo Satoshi;Honma Mitsunobu;Honda Yoshihiro;Tokue Yutaka;Kitamura Naoto;Shoji Satoru;Kikuchi Hiroaki;Motomiya Masakichi;Konno Kiyoshi;Sayama Tsuneo, 1993, CHEMOTHERAPY, 41, 1, 217, 230
• In vitro antimicrobial activity and therapeutic efficacy of teicoplanin in respiratory tract infections caused by gram-positive cocci, Watanabe Akira;Honda Yoshihiro;Tokue Yutaka;Shoji Satoru;Takahashi Hiroshi;Kikuchi Hiroaki;Yanase Kenji;Nakamura Mikae;Takizawa Shigeo, 1993, CHEMOTHERAPY, 41, 2, 167, 172
• In vitro antimicrobial activity of cefozopran and its therapeutic efficacy in respiratory infections, Tokue Yutaka;Shoji Satoru;Takahashi Hiroshi;Kikuchi Hiroaki;Watanabe Akira;Takizawa Shigeo;Nakamura Mikae, 1993, CHEMOTHERAPY, 41, 4, 170, 175
• In vitro antimicrobial activity of temafloxacin and its therapeutic efficacy in respiratory infections, Watanabe Akira;Honda Yoshihiro;Tokue Yutaka;Kitamura Naoto;Shoji Satoru;Kikuchi Hiroaki;Motomiya Masakichi;Honma Mitsunobu, 1993, CHEMOTHERAPY, 41, 5, 308, 314
• Detection of gyrA mutations in Staphylococcus aureus by nonradioisotopic single-strand conformation polymorphism analysis., Tokue Yutaka;Sugano Kokichi, 1994, CHEMOTHERAPY, 42, 3, 283, 289
• In vitro antimicrobial activity and therapeutic efficacy of FK037 in the treatment of respiratory tract infections, Watanabe Akira;Nakamura Mikae;Yanase Kenji;Takizawa Shigeo;Tokue Yutaka;Takahashi Hiroshi;Shoji Satoru;Kikuchi Hiroaki;Motomiya Masakichi;Nukiwa Toshihiro;Honda Yoshihiro;Nakai Yushi, 1994, CHEMOTHERAPY, 42, 3, 145, 152
• Rate of occurrence of mutations at Ser-84 in Staphylococcus aureus DNA gyrase A protein., Takahashi Hirosi;Shoji Satoru;Kikuchi Hiroaki;Watanabe Akira;Nukiwa Toshihiro;Honda Yoshihiro;Tokue Yutaka, 1995, Japanese Journal of Chemotherapy, 43, 5, 515, 519
• Changes in susceptibity of clinical isolates of Staphylococcus aureus to quinolones and other antibacterial agents from 1986 to 1993., Takahashi Hirosi;Shoji Satoru;Kikuchi Hiroaki;Watanabe Akira;Nukiwa Toshihiro;Honda Yoshihiro;Tokue Yutaka, 1995, Japanese Journal of Chemotherapy, 43, 5, 547, 550
• In vitro antimicrobial activity, penetration into sputum and therapeutic efficacy of grepafloxacin in respiratory tract infections, Watanabe Akira;Niizuma Kazunao;Takizawa Shigeo;Yanase Kenji;Nakamura Mikae;Kikuchi Hiroaki;Shoji Satoru;Takahashi Hiroshi;Tokue Yutaka;Motomiya Masakichi;Nukiwa Toshihiro;Honda Yoshihiro;Nakai Yushi, 1995, Japanese Journal of Chemotherapy, 43, 1, 206, 216
• In vitro antimicrobial activity and penetration into sputum of balofloxacin, and its therapeutic efficacy in respiratory tract infections, Watanabe Akira;Sayama Tsuneo;Kashiwagi Makoto;Aso Noboru;Niizuma Kazunao;Takizawa Shigeo;Nakamura Mikae;Shoji Satoru;Takahashi Hiroshi;Kikuchi Hiroaki;Tokue Yutaka;Nukiwa Toshihiro;Motomiya Masakichi;Honma Mitsunobu;Konno Kiyoshi, 1995, Japanese Journal of Chemotherapy, 43, 5, 190, 201
• In vitro antimicrobial activity of NM394, an active form of NM441, and therapeutic efficacy of NM441 in respiratory tract infections, Watanabe Akira;Konno Kiyoshi;Shoji Satoru;Takahashi Hiroshi;Kikuchi Hiroaki;Tokue Yutaka;Nukiwa Toshihiro;Motomiya Masakichi;Nakagawa Jun;Hitomi Hideaki;Sato Kazuo, 1996, Japanese Journal of Chemotherapy, 44, 1, 249, 255
• Pulmonary infection due to Eikenella corrodens: Report of three cases., Takahashi Hiroshi;Watanabe Akira;Kikuchi Toru;Tokue Yutaka;Kobayashi Takao;Shoji Satoru;Honda Yoshihiro;Chiba Junnichi;Fujimura Shigeru;Nukiwa Toshihiro, 1998, Japanese Journal of Chemotherapy, 46, 7, 261, 265
• Inactivation o arbekacin by aminoglycoside-modifying enzymes from arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus., Fujimura Shigeru;Tokue Yutaka;Takahashi Hiroshi;Nukiwa Toshihiro;Watanabe Akira, 1999, Japanese Journal of Chemotherapy, 47, 1, 1, 8
• Antimicrobial activity of NM 394, an active form of prulifloxacin, against clinical isolates of Pseudomonas aeruginosa with a type II topoisomerase mutation., Araake Minako;Watanabe Akira;Tani Mariko;Maebashi Kazunori;Hara Tetsuro;Watabe Hiroomi;Takahashi Hiroshi;Tokue Yutaka;Fujimura Shigeru;Gomi Kazunori, 2003, Japanese Journal of Chemotherapy, 51, 3, 132, 137
• Sepsis caused by methicillin-resistant Staphylococcus aureus (MRSA) without effects of vancomycin (VCM), teicoplanin (TEIC) and arbekacin (ABK) treated successfully and safely with intravenous administration of linezolid (LZD), Ohkouchi Shinya;Gomi Kazunori;Tokue Yutaka;Kikuchi Toshiaki;Fujimure Shigeru;Nukiwa Toshihiro;Watanabe Akira, 2004, Japanese Journal of Chemotherapy, 52, 12, 787, 792
• A Comparative Study Between Cefodizime (CDZM) and Cefotaxime (CTX) in Respiratory Tract Infections, TAKEBE Kazuo;NAKAZONO Makoto;KAWAI Shin;SHIMADA Kaoru;SATO Yasuyuki;MIYAMOTO Yasufumi;TANIMOTO Hiroichi;YOSHIMURA Kunihiko;NAKATANI Tatsuo;CHONABAYASHI Naohiko;NAKAMORI Yoshitaka;NOGUCHI Masayuki;KAWAGISHI Takahiko;NAKATA Koichiro;YAMANE Yoshiji;UENO Katsunori;KATO Tatsuo;WATANABE Kentaro;KOYAMA Masaru;KAWAGUCHI Yoshiaki;IKEMOTO Hideo;WATANABE Kazuyoshi;KOHARA Tomoo;TAMAZAWA Naoki;INAGAKI Masayoshi;FUJIMORI Ippei;KAWABE Hiroshi;KOBAYASHI Yoshio;MATSUOKA Yasuo;OKUBO Takao;ITO Akira;FUKAYA Kazufuto;MATSUMOTO Fumio;ODAGIRI Shigeki;MIYAZAWA Tadashi;MATSUNAGA Keiichiro;SUZUKI Kaneo;MUROHASHI Kou;TAKAHASHI Kenichi;NUMATA Hiroyuki;WATANUKI Yuji;YAMAKI Izumi;ISHII Shunichi;ARAKAWA Masaaki;WADA Koichi;KIMURA Kenichi;TAKATO Masanaga;SEKINE Makoto;AOKI Nobuki;OYAMA Kaoru;OHYA Nobuo;HAYASE Mitsuru;TAKEUCHI Toshihiko;KATO Masahito;HANAKI Hidekazu;KATO Joichi;KOSAKA Shirou;YAMAMOTO Toshiyuki;SUZUKI Kanzo;ADACHI Satoru;YAMAMOTO Kazuhide;MIKI Fumio;IKUNO Yoshiyasu;INOUE Eiji;MURATA Akihito;TANIZAWA Shinichi;SAKAMOTO Kazuo;SAGARA Morio;KAWASE Yoshio;KINUGAWA Fumiaki;SOEJIMA Rinzo;NIKI Yoshito;TASAKA Yoshikazu;NAKAJIMA Masamitus;TSUKIYAMA Kuninori;UMEKI Shigenobu;HINO Jiro;WATANABE Masatoshi;OKAMOTO Katsuhiro;YAGI Susumu;KAWANE Hiroshi;SASAKI Takao;MATSUMOTO Yukio;SUGIMOTO Yuji;HITSUDA Yutaka;HIRAI Hiroaki;YAMAKIDO Michio;HASEGAWA Kenji;KAMIGAKI Ikuo;UEHARA Osamu;YOKOTA Yoshihiro;KAMITSUNA Akimitsu;KURIMURA Osamu;SASAKI Hideo;FUKUHARA Hirofumi;SAWAE Yoshiro;TAKAGI Koji;HARA Kohei;HIROTA Masaki;YAMAGUCHI Keizo;OSONOI Ken;KOHNO Sigeru;HAYASHI Toshiaki;KOGA Hironobu;SUYAMA Naofumi;DOTSU Yasumasa;MASUYAMA Yasuharu;MASHIMOTO Hideo;MASAKI Miyako;INOUE Yuichi;YASUOKA Akira;IMAMURA Kenichi;SAITOU Miyoko;SASAYAMA Kazuo;TOMONO Kazunori;KOMORI Munetaka;NAKANO Masamoto;ITO Naomi;MATSUMOTO Keizo;OISHI Kazunori;TAKAHASHI Atsushi;SHISHIDO Harumi;YAMAMOTO Masashi;HAYASHI Shigeki;ARAKI Shukuro;ANDO Masayuki;SUGA Moritaka;NASU Masaru;GOTO Yoichiro;SHIGENO Hideaki;GOTO Jun;TASHIRO Takayoshi;SHIMIZU Kihachiro;SAITO Akira;TOMIZAWA Masumi;FUJINE Masaru;SHINOHARA Masahide;SATO Mikiya;KUMANO Hiroyuki;KIMURA Osamu;MINAKAMI Hirotoshi;MASUDA Mitsuo;TAKEUCHI Keisuke;AMASAKI Yoshiharu;NAKAYAMA Ichiro;UEHARA Soichiro;HIRAYAMA Akio;HIRAGA Yohmei;OHMICHI Mitsuhide;SASAOKA Shoichi;HAYASHI Masato;HOSOYA Kenichi;MURAKAMI Seiichi;TAMURA Masao;ITO Takashi;KOKUBU Kumi;KURAMITSU Hiroshi;MORIYA Katsura;SATO Nobuhisa;TANIFUJI Kazuo;MIYA Kazumichi;KOBAYASHI Hiroshi;YOSHIDA Tsukasa;TOMIYAMA Masahiko;TAKEUCHI Kenichi;KANAYAMA Hiromi;ITO Toshiharu;TAKAHASHI Keiji;IKEDA Hideki;ITASAKA Miyoko;TAKISHIMA Tamotsu;TANNO Yasuo;NISHIOKA Kiyo;KONNO Kiyoshi;TAMURA Toyokazu;AONUMA Seiichi;TOKUE Yutaka;KITAMURA Naoto;HONDA Yoshihiro;ONO Reiko;WATANABE Akira;SASAKI Masako;OIZUMI Kotaro;SATO Kazuo;HAYASHI Izumi;ENDOU Katsumi;OHNUMA Kikuo;FUKUI Toshio;MIZUKOSHI Kazuo;OKUI Shinji;KATSU Masataka;ABE Tohru;TAKANO Makoto;HOSONO Osamu;KAWAI Takeshi;ONAKA Akio;ISHIMARU Kouhei;HIGASHI Fuyuhiko;FUNATSU Yuzo;UEDA Yasushi;SAITO Atsushi;SHIMADA Jingoro;SHIBA Kohya;MIYAHARA Tadashi;UEDA Yuichiro;ONO Yasuo;BABA Masumi;OKUSHIMA Toshimi;NISHIYA Hajime;NOZUE Norio;MURAOKA Akira;HAGA Toshiaki;MIYASHITA Hideo;UZUKA Yoshio;KOBAYASHI Hiroyuki;OSHITANI Hiroshi;INOUE Hisashi;KAWAHIRA Masahide, 1989, Kansenshogaku Zasshi, 63, 4, 318, 351
• An Optimum Dose-Finding Study of HR810 (CPR) in Chronic Respiratory Tract Infections, SOEJIMA Rinzo;OHMICHI Mitsuhide;WATANABE Akira;OIZUMI Kotaro;HONDA Yoshihiro;TOKUE Yutaka;MOTOMIYA Masakichi;SATO Kazuo;NAGAI Kosaku;SHIMODA Shigeru;KONNO Kiyoshi;HINO Jiro;HAYASHI Izumi;OSHITANI Hiroshi;MIURA Hiroshi;INOUE Takashi;KOBAYASHI Hiroyuki;SHIMADA Kaoru;INAMATSU Takashi;GOTO Mieko;OKA Shinichi;GOTO Hajime;SUMI Masaru;NAKAMORI Yoshitaka;NARUI Koji;NOGUCHI Masayuki;NAKAYA Tatsuo;NAKATA Koichiro;SAKURAI Iwao;IMAI Takeo;MATSUMOTO Fumio;ODAGIRI Shigeki;SUZUKI Kaneo;OKIMOTO Niro;MUROHASHI Kou;TAKAHASHI Hiroshi;ASHIKARI Yasuhiko;KOYAMA Izumi;ISHII Toshikazu;TSUBURA Eiro;NAKAGAWA Masaru;NISHIKAWA Hideki;TAKISHITA Yoshihiro;BANDO Hiroyasu;YAGI Susumu;HASHIMOTO Yoshihiro;ATAGI Shinji;MATSUMOTO Yukio;YAMAMOTO Mitsunobu;KONISHI Tatsuya;SUGIMOTO Yuji;SAKATA Takuya;HIRAI Hiroaki;HITSUDA Yutaka;SASAKI Takao;TSUKIYAMA Kuninori;HARA Kohei;HIROTA Masaki;KOHNO Shigeru;HAYASHI Toshiaki;SUYAMA Naofumi;MIYAZAKI Yukishige;DOHTSU Yasumasa;YASUOKA Akira;KATSUMATA Tatsuya;YAMADA Hiroshi;MATSUSHIMA Toshiharu;YOSHIDA Toshiaki;NAGATAKE Tsuyoshi;AKIYAMA Moritoshi;TAKASUGI Masakazu;TAGUCHI Mikio;WATANABE Kiwao;MATSUMOTO Keizo;NASU Masaru;GOTO Jun;SHIGENO Hideaki;KAWANISHI Masayoshi;GOTO Yoichiro;TASHIRO Takayoshi;NAGAI Hiroyuki;YAMAZAKI Toru;AKASHI Mitsunobu;SAITO Atsushi;FUKUHARA Hiroshi;KANESHIMA Hiroshi;IRABU Yuei;SHIMOJI Katsuyoshi;HIRAGA Yohmei;KITSUKAWA Keizo;SHIGENO Yoshiteru;OGAWA Nobuya, 1991, Kansenshogaku Zasshi, 65, 1, 96, 109
• Clinical Evaluation of Cefuzonam (CZON) for Bacterial Pneumonia and Lung Abscess Comparative Study with Cefotiam (CTM), KOBAYASHI Hiroyuki;TOMIYAMA Tsukiko;KIMURA Kenichi;KANNARI Kazuya;KOSAKA Shiro;KONNO Kiyoshi;OIZUMI Kotaro;WATANABE Akira;TOKUE Yutaka;ONO Reiko;HONDA Yoshihiro;OSHITANI Hiroshi;SHOJI Satoshi;KITAMURA Naoto;HAYASHI Izumi;ARAKAWA Masaaki;TAKATO Masanaga;WADA Koichi;SUZUKI Norio;SHIMADA Kaoru;SANO Yasuyuki;ARAI Yasuo;YOSHIDA Masahiko;TANIMOTO Hiroichi;NAKATA Koichiro;NAKAMORI Yoshitaka;NAKATANI Tatsuo;NARUI Hiroshi;ODAGIRI Shigeki;SUZUKI Kaneo;MUROHASHI Kou;NUMATA Hiroyuki;TAKAHASHI Kenichi;SAITO Akira;KOYAMA Izumi;ISHII Shunichi;MIKI Fumio;SOEJIMA Rinzo;HINO Jiro;MATSUSHIMA Toshiharu;TANABE Jun;KURIMURA Osamu;SASAKI Hideo;FUKUHARA Hirofumi;NAKAYAMA Ichiro;MORIMOTO Tadao;HARA Kohei;KOHNO Shigeru;KOGA Hironobu;DOUTSU Yasumasa;HAYASHI Toshiaki;KAKU Mitsuo;KANZAKI Shinichiro;NAKATOMI Masao;KOHNO Kohta;TAKEBE Kazuo;KITANI Takakazu;TOMITA Hiroshi;SAKITO Osamu;MATSUMOTO Keizo;NAGATAKE Tsuyoshi;RIKITOMI Naoto;TAKAHASHI Atsushi;TAKASUGI Masakazu;MASAKI Hironori;NASU Masaru;MASUDA Mitsuo;GOTO Yoichiro;SHIGENO Hideaki;GOTO Jun;TASHIRO Takayoshi;SAITO Atsushi;SHIGENO Yoshiteru;IRABU Yuei;YAMAGUCHI Keizo;SUGAHARA Kazuyuki;MOCHIDA Chikako;MURAKAMI Seiichi;NAKASHIMA Mitsuyoshi;TANAKA Hiroaki, 1991, Kansenshogaku Zasshi, 65, 4, 381, 399
• A Comparative Study of Cefepime for Chronic Respiratory Tract Infections, SAITO Atsushi;SHIMIZU Tetsuo;SATO Kei;OHIZUMI Kohtaro;ICHIKAWA Youichiro;TANAKA Masako;FUJINO Kazuma;MITSUTAKE Yoshiyuki;KUBUSHIRO Mikio;HIGASHI Toshihiro;HARADA Susumu;HARADA Yasuko;SASAKI Nobuhiro;HARA Kohei;KOHNO Shigeru;KOGA Hironobu;KAKU Mitsuo;MATSUMOTO Keizo;OHISHI Kazunori;TANAKA Hiroshi;SHIMA Kiyoshi;TAKENAKA Shinobu;NASU Masaru;FUJIKANE Toshiaki;GOTO Yoichiro;YAMAZAKI Tohru;NAGAI Hiroyuki;TASHIRO Takayoshi;OGAWA Nobuya;KUSANO Nobuchika;FUJITA Yuka;HIROSHIMA Takashi;SAKAI Eiichi;SAITO Akira;HIRAGA Yohmei;OHMICHI Mitsuhide;YOSHIDA Tsukasa;SHIGENO Yoshiteru;KANAYAMA Hiromi;ITO Toshiharu;TAKISHIMA Tamotsu;TANNO Yasuo;SATO Ruriko;TAKAHASHI Makoto;SUGIYAMA Masaharu;MOTOMIYA Masakichi;WATANABE Akira;HONDA Yoshihiro;IRABU Yuei;TOKUE Yutaka;NIIZUMA Kazunao;TAKIZAWA Shigeo;KATSU Masataka;TORIKAI Katsutaka;SUETSUGU Susumu;YOSHIDA Shunji;SHIMADA Kaoru;SANO Yasuyuki;ARAI Yasuo;FUKUHARA Hiroshi;KOSHINO Takeru;OGAWA Tetsuhei;KOBAYASHI Yoshio;KOBAYASHI Hiroyuki;OKUBO Takao;IKEDA Hirotada;ODAGIRI Shigeki;MATSUMURA Masanori;ASHIKARI Yasuhiko;AMANO Yasutsugu;OHSHIRO Hajime;SHOJI Akira;SAKUMA Takashi;AOKI Nobuki;TAKAGI Kenzo;YAMAKI Kenichi;SUZUKI Kiyoshi;NODA Yasunobu;GONDA Hideo;TAKEUCHI Toshihiko;KATO Johichi;MIYAKUNI Takahiko;KUZE Fumiyuki;MURAYAMA Takako;IKEDA Nobuaki;NAKATANI Koichi;BANDO Kenji;IKEDA Souichiro;KURODA Tadaaki;NARITA Nobuhiro;SAWAKI Masayoshi;MIKASA Keiichi;INATOME Jun;MIKI Fumio;SOEJIMA Rinzo;NIKI Yoshihito;HINO Jiro;SUMI Masaru;MATSUSHIMA Toshiharu;KAWANISHI Masayoshi;KIMURA Makoto;HIRAKI Shunkichi;WATANABE Yohichi;ONODERA Soukichi;ARAKI Masashi;YAMAKIDO Michiro;HASEGAWA Kenji;TSUYA Takashi;SADAMOTO Kenichiro;KUWABARA Masao;OKADA Masanobu;ARITA Kenichi;DOI Masao;DAIDO Kazuhiro;NAKANO Hitoshi;YANAGIDA Jitsuro;WATANABE Kenichiro;ATA Yuichi;SUGIHARA Motohiro;YUKUTAKE Masato;AWAYA Kouichi;IHARA Yoshihisa;YOSHIDA Minoru;WATANABE Kentaro;HIROSE Takahito, 1992, Kansenshogaku Zasshi, 66, 7, 886, 908
• A Comparative Study of Cefepime for Bacterial Pneumonia, SAITO Atsushi;FUJITA Yuka;TERAMOTO Hidemi;YAMAKIDO Michiro;HASEGAWA Kenji;TSUYA Takashi;SADAMOTO Kenichiro;KUWABARA Masao;OKADA Masanobu;ARITA Kenichi;DOI Masao;DAIDO Kazuhiro;HIROSHIMA Takashi;YANAGIDA Jitsuro;WATANABE Kenichiro;ATA Yuichi;SUGIHARA Motohiro;YUKUTAKE Masato;AWAYA Kouichi;IHARA Yoshihisa;SAWAE Yoshihiro;SHIMONO Nobuyuki;KUMAGAI Yukio;SAKAI Eiichi;HIROSE Takahito;SATO Kei;OHIZUMI Kohtaro;ICHIKAWA Youichiro;TANAKA Masako;MITSUTAKE Yoshiyuki;FUJINO Kazuma;KUBUSHIRO Mikio;HIGASHI Toshihiro;HARA Kohei;SAITO Akira;KOHNO Shigeru;KOGA Hironobu;KAKU Mitsuo;MATSUMOTO Keizo;OHISHI Kazunori;SHIMA Kiyoshi;TAKENAKA Shinobu;NASU Masaru;GOTO Yoichiro;YAMAZAKI Tohru;NAKAYAMA Ichiro;NAGAI Hiroyuki;TASHIRO Takayoshi;NAGAOKA Hiroshi;NAKAMA Kaoru;OGAWA Nobuya;KUSANO Nobuchika;HIRAGA Yohmei;OHMICHI Mitsuhide;TAKEBA Kazuo;OSONOI Ken;SAITO Miyoko;SHIGENO Yoshiteru;KURODA Hirohisa;TAMURA Masao;KONISHI Kazuki;MORI Yoshiaki;OBARA Akiho;OBARA Kazuo;KOBAYASHI Hitoshi;OGAWA Junichi;KUDO Kunio;ISHII Munehiko;IRABU Yuei;MOTOMIYA Masakichi;WATANABE Akira;HONDA Yoshihiro;TOKUE Yutaka;HONMA Mitsunobu;KATSU Masataka;KUGA Keisuke;KABE Junzaburou;ARIOKA Hitoshi;ARIOKA Hiroko;FUKUHARA Hiroshi;KOYAMA Masaru;NAKATA Kouichiro;NAKAMORI Yoshitaka;SAKAI Osamu;SHIMADA Jingorou;SHIBA Kohya;YOSHIDA Masaki;TANIMOTO Hiroichi;OBARA Kazuo;OKAMURA Tetsuo;ONODERA Soukichi;KOBAYASHI Hiroyuki;SAKAYORI Toru;OSHITANI Hiroshi;TAKEDA Hiroaki;IRIMAJIRI Shoichiro;MATSUOKA Yasuo;OBANA Mitsuo;OKUBO Takao;IKEDA Hirotada;MATSUMOTO Fumio;NAKANO Hitoshi;SAKURAI Iwao;TAKAHASHI Takayuki;ODAGIRI Shigeki;TAKAHASHI Hiroshi;TAKAHASHI Kenichi;AMANO Yasutsugu;SAKUMA Takashi;ARAKAWA Masaaki;WADA Koichi;KAWASHIMA Takashi;SHIMIZU Tetsuo;TAKATO Masanaga;HOSHINO Shigeyuki;SEKINE Osamu;SUZUKI Yasutoshi;TAKEUCHI Toshihiko;HAYASHI Yoshimitsu;YAMAMOTO Kazuhide;YAMAMOTO Toshihiko;SUZUKI Kanzo;MATSUURA Toru;SASAKI Nobuhiro;ADACHI Satoru;KUZE Fumiyuki;MURAYAMA Takako;INABA Nobuo;ODA Yoshio;KAGIOKA Akira;MIKI Fumio;SOEJIMA Rinzo;NIKI Yoshihito;HINO Jiro;HASHIZUME Hirotaka;SUMI Masaru;MATSUSHIMA Toshiharu;KAWANISHI Masayoshi;KIMURA Makoto;HIRAKI Shunkichi;WATANABE Yohichi;ARAKI Masashi;SASAKI Takao;MATSUMOTO Yukio;SUGIMOTO Yuji, 1992, Kansenshogaku Zasshi, 66, 7, 859, 885
• CLINICAL STUDIES ON S 6472 GRANULE PREPARATION (SUSTAINED-RELEASE CEFACLOR) IN CHRONIC RESPIRATORY TRACT INFECTIONS, AONUMA SEIICHI;OIZUMI KOTARO;WATANABE AKIRA;TOKUE YUTAKA;HONDA YOSHIHIRO;ONO REIKO;KITAMURA NAOTO;KONNO KIYOSHI;SATOH KAZUO, 1988, The Japanese Journal of Antibiotics, 41, 9, 1309, 1312
• in vitro ACTIVITY OF BIAPENEM (BIPM) AGAINSTCLINICALLY ISOLATED RESPIRATORY PATHOGENS IN 1996-199, WATANABE AKIRA;SHOJI SATORU;HONDA YOSHIHIRO;TOKUE YUTAKA;TAKAHASHI HIROSHI;KIKUCHI TORU;KOBAYASHI TAKAO;GOMI KAZUNORI;FUJIMURA SHIGERU;YASUI SATOKO;NUKIWA TOSHIHIRO, 1999, The Japanese Journal of Antibiotics, 52, 12, 690, 694
• In vitro antimicrobial activity of loracarbef and its therapeutic efficacy in respiratory tract infections, Watanabe Akira;Honda Yoshihiro;Tokue Yutaka;Shoji Satoru;Kikuchi Hiroaki;Takahashi Hiroshi;Motomiya Masayoshi;Nakamura Toshio;Togashi Hideo, 1993, CHEMOTHERAPY, 41, 3, 168, 177
• Activities of Infection Control and Prevention Center in Gunma University Hospital, Tokue Yutaka, Aug. 2018, The Kitakanto Medical Journal, 68, 3, 175, 176
• COVID-19 Pneumonia in a Patient in Her Seventies that Improved without Antiviral Drug Treatment： A Case Study, MIYAZAWA Yuri;YANAGISAWA Kunio;OGAWA Yoshiyuki;KOISO Hiromi;TOKUE Yutaka;HANDA Hiroshi, Jul. 2020, Kansenshogaku Zasshi, 94, 4, 568, 572
• [Methicillin-resistant Staphylococcus aureus infection]., Tokue Yutaka, Nihon rinsho. Japanese journal of clinical medicine, 65 Suppl 3
• 耐性菌シンポジウム2019　CPE/CRE感染症への対策と実践　CRE/CPEのスクリーニング法, ;;;;, Mar. 2019, 67, Suppl.A, 194
• [Usefulness of sputum examination]., Tokue Yutaka, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 100, 12

  DOI
• Seroprevalence of measles- and mumps-specific immunoglobulin G among Japanese healthcare students increased during 2007-2012., Kimura Takao;Tsunekawa Katsuhiko;Ogiwara Takayuki;Tokue Yutaka;Nara Makoto;Inoue Toshiya;Obuchi Toshiko;Suto Chiaki;Ohshima Kihachi;Murakami Masami, Japanese journal of infectious diseases, 66, 5

  DOI
• ユニバ-サルプレコ-ションの教育と啓蒙 (あゆみ ユニバ-サルプレコ-ション), 徳江 豊, Jan. 1997, 180, 3, 161, 164
• PCR法の院内感染への応用 (PCR法最前線--基礎技術から応用まで), 徳江 豊;菅野 康吉, Apr. 1996, Protein,nucleic acid and enzyme, 41, 5, 705, 707
• Cost-effectiveness for the treatment of community-acquired pneumonia, 徳江 豊, Mar. 2008, 63, 3, 425, 430
• PCR法を用いるMRSAの判定, 徳江豊, 1992, 50, 920, 922
• Antimicrobial activity of NM 394, an active from of prulifloxacin, against clinical isolates of Pseudomonas aeruginosa with a type II topoisomerase mutation, ARAAKE Minako;TANI Mariko;MAEBASHI Kazunori;HARA Tetsuro;WATABE Hiroomi;TAKAHASHI Hiroshi;TOKUE Yutaka;FUJIMURA Shigeru;GOMI Kazunori;WATANABE Akira, Mar. 2003, 51, 3, 132, 137
• The Assessment of the Efficacy and Safety of Favipiravir for Patients with SARS-CoV-2 Infection: A Multicenter Non-randomized, Uncontrolled Single-arm Prospective Study, Yanagisawa, Kunio;Takara, Katsuhiko;Suga, Hiroyuki;Saito, Akio;Hayashi, Toshimasa;Igarashi, Tsuneo;Tomizawa, Sachi;Saito, Etsuko;Sumiyoshi, Hisako;Ohyama, Yoshiaki;Tokue, Yutaka;Nakamura, Tetsuya, 2022, INTERNAL MEDICINE, 61, 21, 3197, 3204

  DOI
• A case of cholangiocarcinoma complicating liver abscess-related tumor thrombus extending via the inferior vena cava to the right ventricle and visualized on transthoracic echocardiography, Kato, Toshimitsu;Yanagisawa, Kunio;Okada, Kenya;Tsukagoshi, Mariko;Tokue, Yutaka;Shirabe, Ken;Tsushima, Yoshito, 2023, JOURNAL OF MEDICAL ULTRASONICS

  DOI
• 臨床研修を練る会議～外来研修&評価(続編)～　群馬大学医学部附属病院における初期臨床SES研修の取り組み　診療領域・職種横断的なチーム活動などへの参加と研修評価, ;;;;;;;;;, Jul. 2022, 53, Suppl., 36
• 薬剤師・臨床検査技師における手指衛生遵守率と意識向上への取り組み, ;;;;;;, Jun. 2022, 37回, O44
• バンコマイシン(VCM)血中濃度の評価方法の変更による腎機能障害発現リスクの検証, ;, Mar. 2023, 71, 2, 178
• 免疫再構築症候群として膵結核を発症したAIDSの一例, ;;;;;, Mar. 2023, 97回・71回, O
• 【薬との「つながり」、薬による「変化」がわかる病態生理学】(第2章)呼吸器　感染, 徳江 豊, May 2023, 65, 7, 1303
• The Assessment of the Efficacy and Safety of Favipiravir for Patients with SARS-CoV-2 Infection: A Multicenter Non-randomized, Uncontrolled Single-arm Prospective Study., Yanagisawa Kunio;Takara Katsuhiko;Suga Hiroyuki;Saito Akio;Hayashi Toshimasa;Igarashi Tsuneo;Tomizawa Sachi;Saito Etsuko;Sumiyoshi Hisako;Ohyama Yoshiaki;Tokue Yutaka;Nakamura Tetsuya, Aug. 2022, Internal medicine (Tokyo, Japan), 61, 21

  DOI
• A case of cholangiocarcinoma complicating liver abscess-related tumor thrombus extending via the inferior vena cava to the right ventricle and visualized on transthoracic echocardiography., Kato Toshimitsu;Yanagisawa Kunio;Okada Kenya;Tsukagoshi Mariko;Tokue Yutaka;Shirabe Ken;Tsushima Yoshito, Sep. 2023, Journal of medical ultrasonics (2001)

  DOI
• 梅毒性ぶどう膜炎診療の適正化に向けた院内連携の試み, ;;;;;;;;, Aug. 2023, 77, 8, 995

MISC

• Vitro susceptibility of clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) to manufactured generic drugs compared with the brand vancomycin, Shigeru Fujimura; Akira Watanabe; Katsuhiro Fuse; Toshiaki Kikuchi; Kazunori Gomi; Yutaka Tokue, Apr. 2008, INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 31, 4, 391, 392, Report scientific journal

  DOI
• Vitro susceptibility of clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) to manufactured generic drugs compared with the brand vancomycin, Shigeru Fujimura; Akira Watanabe; Katsuhiro Fuse; Toshiaki Kikuchi; Kazunori Gomi; Yutaka Tokue, Apr. 2008, INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 31, 4, 391, 392, Report scientific journal

  DOI
• Association between mycobacterial genotypes and disease progression in Mycobacterium avium pulmonary infection, T. Kikuchi; A. Watanabe; K. Gomi; T. Sakakibara; K. Nishimori; H. Daito; S. Fujimura; R. Tazawa; A. Inoue; M. Ebina; Y. Tokue; M. Kaku; T. Nukiwa, Oct. 2009, THORAX, 64, 10, 901, 907

  DOI
• Tuberculosis Screening Using a T-Cell Interferon-gamma Release Assay in Japanese Medical Students and Non-Japanese International Students, Takayuki Ogiwara; Takao Kimura; Yutaka Tokue; Rumi Watanabe; Makoto Nara; Toshiko Obuchi; Akiko Yaegashi; Sachie Yomoda; Kihachi Ohshima; Masami Murakami, Jun. 2013, TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 230, 2, 87, 91

  DOI
• Tuberculosis Screening Using a T-Cell Interferon-gamma Release Assay in Japanese Medical Students and Non-Japanese International Students, Takayuki Ogiwara; Takao Kimura; Yutaka Tokue; Rumi Watanabe; Makoto Nara; Toshiko Obuchi; Akiko Yaegashi; Sachie Yomoda; Kihachi Ohshima; Masami Murakami, Jun. 2013, TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 230, 2, 87, 91

  DOI
• Seroprevalence of Measles- and Mumps-Specific Immunoglobulin G among Japanese Healthcare Students Increased during 2007-2012, Takao Kimura; Katsuhiko Tsunekawa; Takayuki Ogiwara; Yutaka Tokue; Makoto Nara; Toshiya Inoue; Toshiko Obuchi; Chiaki Suto; Kihachi Ohshima; Masami Murakami, Sep. 2013, JAPANESE JOURNAL OF INFECTIOUS DISEASES, 66, 5, 411, 415

  DOI
• Seroprevalence of Measles- and Mumps-Specific Immunoglobulin G among Japanese Healthcare Students Increased during 2007-2012, Takao Kimura; Katsuhiko Tsunekawa; Takayuki Ogiwara; Yutaka Tokue; Makoto Nara; Toshiya Inoue; Toshiko Obuchi; Chiaki Suto; Kihachi Ohshima; Masami Murakami, Sep. 2013, JAPANESE JOURNAL OF INFECTIOUS DISEASES, 66, 5, 411, 415

  DOI
• Mouse and human cell activation by N-dodecanoyl-DL-homoserine lactone, a Chromobacterium violaceum autoinducer, Kazunori Gomi; Toshiaki Kikuchi; Yutaka Tokue; Shigeru Fujimura; Akiko Uehara; Haruhiko Takada; Akira Watanabe; Toshihiro Nukiwa, Dec. 2006, INFECTION AND IMMUNITY, 74, 12, 7029, 7031

  DOI
• Mouse and human cell activation by N-dodecanoyl-DL-homoserine lactone, a Chromobacterium violaceum autoinducer, Kazunori Gomi; Toshiaki Kikuchi; Yutaka Tokue; Shigeru Fujimura; Akiko Uehara; Haruhiko Takada; Akira Watanabe; Toshihiro Nukiwa, Dec. 2006, INFECTION AND IMMUNITY, 74, 12, 7029, 7031

  DOI
• Antibacterial activity of carbapenems against clinically isolated respiratory bacterial pathogens in Japan between 2003 and 2004, A Watanabe; Y Tokue; T Kikuchi; K Gomi; S Aoki; T Satoh; S Fujimura, Nov. 2005, INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 26, 5, 420, 423, Report scientific journal

  DOI
• Antibacterial activity of carbapenems against clinically isolated respiratory bacterial pathogens in Japan between 2003 and 2004, A Watanabe; Y Tokue; T Kikuchi; K Gomi; S Aoki; T Satoh; S Fujimura, Nov. 2005, INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 26, 5, 420, 423, Report scientific journal

  DOI
• Involvement of fractalkine/CX3CL1 expression by dendritic cells in the enhancement of host immunity against Legionella pneumophila, T Kikuchi; S Andarini; H Xin; K Gomi; Y Tokue; Y Saijo; T Honjo; A Watanabe; T Nukiwa, Sep. 2005, INFECTION AND IMMUNITY, 73, 9, 5350, 5357

  DOI
• Involvement of fractalkine/CX3CL1 expression by dendritic cells in the enhancement of host immunity against Legionella pneumophila, T Kikuchi; S Andarini; H Xin; K Gomi; Y Tokue; Y Saijo; T Honjo; A Watanabe; T Nukiwa, Sep. 2005, INFECTION AND IMMUNITY, 73, 9, 5350, 5357

  DOI
• Isoleucyl-tRNA synthetase mutations in Staphylococcus aureus clinical isolates and in vitro selection of low-level mupirocin-resistant strains, S Fujimura; Y Tokue; A Watanabe, Oct. 2003, ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 47, 10, 3373, 3374, Report scientific journal

  DOI
• JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy - The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG, Keiichi Mikasa; Nobuki Aoki; Yosuke Aoki; Shuichi Abe; Satoshi Iwata; Kazunobu Ouchi; Kei Kasahara; Junichi Kadota; Naoki Kishida; Osamu Kobayashi; Hiroshi Sakata; Masahumi Seki; Hiroki Tsukada; Yutaka Tokue; Fukumi Nakamura-Uchiyama; Futoshi Higa; Koichi Maeda; Katsunori Yanagihara; Koichiro Yoshida, Jul. 2016, JOURNAL OF INFECTION AND CHEMOTHERAPY, 22, S, S1, S65

  DOI
• JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy - The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG, Keiichi Mikasa; Nobuki Aoki; Yosuke Aoki; Shuichi Abe; Satoshi Iwata; Kazunobu Ouchi; Kei Kasahara; Junichi Kadota; Naoki Kishida; Osamu Kobayashi; Hiroshi Sakata; Masahumi Seki; Hiroki Tsukada; Yutaka Tokue; Fukumi Nakamura-Uchiyama; Futoshi Higa; Koichi Maeda; Katsunori Yanagihara; Koichiro Yoshida, Jul. 2016, JOURNAL OF INFECTION AND CHEMOTHERAPY, 22, S, S1, S65

  DOI
• Criteria for safety evaluation of antimicrobial agents, Akira Watanabe; Yutaka Tokue; Nobuki Aoki; Tetsuro Matsumoto; Katsunori Yanagihara; Futoshi Higa; Hiroyuki Tsuge; Masahito Nagashima; Hiromi Matsuoka; Yuji Sasagawa; Masato Matsumoto; Kazuo Fujimaki; Kenji Taguchi; Mari Ariyasu; Norifumi Yamamoto; Otohiko Kunii; Kohya Shiba, Feb. 2011, JOURNAL OF INFECTION AND CHEMOTHERAPY, 17, 1, 139, 147

  DOI
• Criteria for safety evaluation of antimicrobial agents, Akira Watanabe; Yutaka Tokue; Nobuki Aoki; Tetsuro Matsumoto; Katsunori Yanagihara; Futoshi Higa; Hiroyuki Tsuge; Masahito Nagashima; Hiromi Matsuoka; Yuji Sasagawa; Masato Matsumoto; Kazuo Fujimaki; Kenji Taguchi; Mari Ariyasu; Norifumi Yamamoto; Otohiko Kunii; Kohya Shiba, Feb. 2011, JOURNAL OF INFECTION AND CHEMOTHERAPY, 17, 1, 139, 147

  DOI
• Antibacterial activity of carbapenems against clinical isolates of respiratory bacterial pathogens in the northeastern region of Japan in 2007, Kazunori Gomi; Shigeru Fujimura; Katsuhiro Fuse; Hidenari Takane; Yoshihisa Nakano; Yasuko Kariya; Toshiaki Kikuchi; Iku Kurokawa; Yutaka Tokue; Akira Watanabe, Apr. 2011, JOURNAL OF INFECTION AND CHEMOTHERAPY, 17, 2, 200, 206

  DOI
• Antibacterial activity of carbapenems against clinical isolates of respiratory bacterial pathogens in the northeastern region of Japan in 2007, Kazunori Gomi; Shigeru Fujimura; Katsuhiro Fuse; Hidenari Takane; Yoshihisa Nakano; Yasuko Kariya; Toshiaki Kikuchi; Iku Kurokawa; Yutaka Tokue; Akira Watanabe, Apr. 2011, JOURNAL OF INFECTION AND CHEMOTHERAPY, 17, 2, 200, 206

  DOI
• 特集 呼吸器感染症の話題ー下気道感染症ー, 徳江 豊; 貫和敏博, 2001, 94-101
• 呼吸器感染症の分子生物学 1. 病源微生物のゲノム情報，Molecular Biologyを基礎にした呼吸器疾患の理解：2001／2002 Update., 徳江 豊, 2001, 60:4-8
• 呼吸器感染症診断の進歩 非定型肺炎：Ｑ熱、クラミジア、マイコプラズマ, 徳江 豊, 2002, 21:910-913
• 癌病棟における感染症の特徴とその対策 肺癌, 徳江 豊; 渡辺彰, 2003, 15:185-192
• 肺炎の病態2；抗菌薬はなぜ効くのか 肺炎についての基礎知識, 徳江 豊, 2004, 30:1499-1503
• 感染症研究の進歩とその臨床的インパクト 多剤耐性結核, 徳江 豊, 2005, 13:257-260
• 感染症診療最前線 PK/PD（薬物動態・薬力学）を指標とする抗菌薬の効果的投与法, 徳江 豊, 2005, 96:826-830
• Comparative in-vitro activity of carbapenem antibiotics against respiratory pathogens isolated between 1999 and 2000, A. Watanabe; Y. Tokue; H. Takahashi; T. Kikuchi; T. Kobayashi; K. Gomi; S. Fujimura; S. Yasui; Y. Murayama; T. Nukiwa, 2001, Journal of Infection and Chemotherapy, 7, 4, 267, 271

  DOI
• Charithromycin suppresses lipopolysaccharide-induced interleukin -8 production by human monocytes through AP-1 and NF-kB transcription factors, TOKUE YUTAKA; kikuchi Toru, 2002, 49: 745-755
• Mouse SWAM1 and SWAM2 are antibacterial proteins composed of a single whey acidic protein (WAP) motif, TOKUE YUTAKA; Hagiwara Koichi, 2003, 170: 1973-1979
• Isoleucyl-tRNA synthetase mutations in Staphylococcus aureus clinical isolates and in vitro selection of low-level mupirocin-resistant strains, TOKUE YUTAKA; Fujimura Shigeru, 2003, 47: 3373-3374

  DOI
• Dendritic cells pulsed with live and dead Legionella pneumophila elicit distinct immune responses, TOKUE YUTAKA; Kikuchi Toshiaki, 2004, 172: 1727-1734
• Mannose-binding lectin gene polymorphism is a modulating factor in repeated respiratory infections, TOKUE YUTAKA; Gomi Kazunori, 2004, 126: 95-99

  DOI
• 市中肺炎診療と医療経済性 市中肺炎治療とガイドライン, 徳江豊, 2008, 63, 3, 65, 70
• Severe acute interstitial pneumonia and gefitinib, TOKUE YUTAKA; Inoue Akira, 2003, 361: 137-139

  DOI
• セファロスポリン系抗菌薬 臨床で活かす各系統の抗菌薬の特性 抗菌薬の特性を活かして上手に使うコツ, 徳江豊, 2007, 10, 2, 166, 170
• Identification of mycobacteria by nonradioisotopic single-strand conformation polymorphism analysis., TOKUE YUTAKA; Sugano Kokichi, 1995, 23: 129-133

  DOI
• Eyelid metastasis from breast cancer showing marked response to chemotherapy, TOKUE YUTAKA; Zhang GJ, 1995, 25: 10-15
• Colonoscopy for frank bloody stools associated with cancer chemotherapy, TOKUE YUTAKA, 1997, 27: 111-114

  DOI
• Increased levels of mitochondrial DNA in an etoposide-resistant human monocytic leukaemia cell line (THP-1/E), TOKUE YUTAKA; Saijo Yasuo, 1991, 27: 1436-1440
• Detection of methicillin-resistant Staphylococcus aureus (MRSA) using polymerase chain reaction amplification, TOKUE YUTAKA; Shoji Satoru, 1991, 161: 31-37
• Comparison of a polymerase chain reaction assay and a conventional microbiologic method for detection of methicillin-resistant Staphylococcus aureus, TOKUE YUTAKA; Shoji Satoru, 1992, 36: 31-37

  DOI
• Detecting methicillin resistance in Staphylococcus aureus by polymerase chain reaction-reply, TOKUE YUTAKA, 1992, 36: 1585-1586
• Detection of novel mutations in the gyrA gene of Staphylococcus aureus by nonradioisotopic single-strand conformation polymorphism analysis and direct DNA sequencing., TOKUE YUTAKA; Sugano Kokichi, 1994, 38: 428-431

  DOI
• DNA gyrase gyrA gene mutations in ofloxacin-resistant Staphylococcus aureus, TOKUE YUTAKA; Sugano Kokichi, 1995, 6: 129-133

  DOI
• A newly recognized acetylated metabolite of arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus, TOKUE YUTAKA; Fujimura Shigeru, 1998, 41: 495-497

  DOI
• CD44 variant isoform expression and breast cancer prognosis, TOKUE YUTAKA; Mastumura Yasuhiro, 1998, 89: 283-290
• A Phase I Trial of Docetaxel and 5-day continuous infusion of 5-Fluorouracil in Patients with Advanced or Recurrent Breast Cancer, TOKUE YUTAKA; Ando Masashi, 1998, 77: 1937-1943
• In vitro activity of HSR-903, a new oral quinolone, against bacteria causing respiratory infections, TOKUE YUTAKA; Watanabe Akira, 1999, 43: 1767-1768
• In vitro antimicrobial activity and penetration rate into sputum of gatifloxacin, a novel 6-fluoro-8-methoxy quinolone, and its therapeutic efficacy in respiratory infections, Akira Watanabe; Tohru Kikuchi; Afzalunnesa Binte Lutfor; Yutaka Tokue; Hiroshi Takahashi; Shigeru Fujimura; Satoru Shoji; Yoshihiro Honda; Ytishi Nakai; Toshihiro Nukiwa, 1999, Journal of Infection and Chemotherapy, 5, 3, 149, 155

  DOI
• Comparative in vitro activity of S-4661, a new parenteral carbapenem, and other antimicrobial agents against respiratory pathogens, TOKUE YUTAKA; Watanabe Akira, 2000, 46: 184-187

  DOI
• Novel arbekacin- and amikacin-modifying enzyme of methicillin-resistant Staphylococcus aureus, TOKUE YUTAKA; Fujimura Shigeru, 2000, 190: 299-303

  DOI
• Construction and Validation of a Practical Prognostic Index for Patients With Metastatic Breast Cancer, TOKUE YUTAKA; Yamamoto Noboru, 1998, 16: 2401-2408
• Characterization of resistance to VP-16 in human leukemic cell line, TOKUE YUTAKA; Saijo Y, 1989, 159: 299-306

  DOI
• Reduced topoisomerase 2-mediated DNA cleavage in VP-16 resistant human leukemic cell line, TOKUE YUTAKA; Saijo Yasuo, 1991, 11: 445-448
• Comparative in vitro activity of vancomycin and other antimicrobial agents against MRSA and Enterococcus faecium in Tohoku district of Japan, TOKUE YUTAKA; Lutffor AB, 1998, 44: 318-323

  DOI
• Comparative in vitro activity of carbapenem antibiotics against respiratory pathogens isolated in recent years, Akira Watanabe; Hiroaki Kikuchi; Tohru Kikuchi; Afzalunnesa Binte Lutfor; Yutaka Tokue; Hiroshi Takahashi; Shigeru Fujimura; Saforu Shoji; Yoshihiro Honda; Yushi Nakai; Toshihiro Nukiwa, 1999, Journal of Infection and Chemotherapy, 5, 3, 171, 175

  DOI
• High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein acrA, TOKUE YUTAKA; Mazzariol A, 2000, 44: 3441-3443

  DOI
• Tumor-associated fever in recurrent breast cancer with liver metastases, TOKUE YUTAKA; Zhang GJ, 1994, 1: 145-150
• Incidence of various gyrA mutations in 451 Staphylococcus aureus strains isolated in Japan and their susceptibilities to 10 fluoroquinolones., TOKUE YUTAKA; Takenouchi Takashi, 1995, 39: 1414-1418

  DOI
• Characterization of gyrA, gyrB, grlA and grlB mutations in fluoroquinolone-resistant clinical isolates of Staphylococcus aureus, TOKUE YUTAKA; Takahashi Hiroshi, 1998, 41: 49-57

  DOI
• Specificity of 4'''-acetylation by an aminoglycoside-modifying enzyme in arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus, TOKUE YUTAKA; Fujimura Shigeru, 1998, 186: 67-70

  DOI
• PK/PDとは何か？臨床ではどう役に立つのか？, 徳江豊, 2008, 28, 1400
• 感染曝露vsPPE 外来ー採血時の手袋, 小渕俊子; 徳江豊, 2009, 4, 3, 262, 266
• 新規抗菌薬の特徴とその使い方 感染症の治療―抗菌薬を使いこなそう, 徳江豊, 2008, 102, 948, 951
• 血液腫瘍内科病棟に入院中の患者にインフルエンザ発生, 徳江豊, 2009, 53, 1482, 1483

  DOI
• 新規抗真菌薬voriconazoleが著効した高齢者肺アスペルギルス症の1例, 久田剛志; 多湖洋子; 青木秀夫; 石塚全; 徳江豊; 土橋邦生; 森昌朋, 2006, 65, 8, 740, 748
• 耐性菌の出現はどうすれば抑制できるか？, 荻原貴之; 徳江豊, 2007, 16, 7, 630, 636
• 医療関連肺炎（I-ROAD）感染症, 徳江豊, 2010, 105, 1219, 1222
• カルバペネム系抗菌薬選択の分岐点―マクロの観点・ミクロの視点 カルバペネム系抗菌薬を使う・使わないの臨床決断, 徳江豊, 2008, 11, 117, 120
• セフェム系抗菌薬 感染症の外来診療―経口抗菌薬の上手な使い分け, 徳江豊, 2010, 13, 127, 131
• 臨床で注意する肺炎の重症化・難治化因子, 徳江 豊, 2013, 16, 2, 97, 100
• A Striking Increase in Seroprevalence of Measles-Specific Immunoglobulin G Among Native Japanese Healthcare Students: The Impact of a Five-Year Measles-Rubella Vaccination Catch-Up Campaign in Japan., Kimura T; Takeichi A; Inoue T; Suto C; Tsunekawa K; Nara M; Tokue Y; Murakami M, 2015, 91, 127, 133
• Comparison of 16S ribosomal RNA gene sequence analysis and conventional culture in the environmental survey of a hospital, Manaka A; Tokue Y; Murakami M, 2017, 3, 8

  DOI
• 尿中抗原診断法の現状と将来 特集 感染症：診断と治療の進歩, 徳江豊, 2010, 99, 2696, 2702

  DOI
• レスピラトリーキノロン系薬の適正使用, 徳江豊, 2011, 4546, 77, 82
• 喀痰検査はどこまで有用か？ 特集 感染症：肺炎の診療―ガイドラインのシンポ, 徳江豊, 2011, 100, 3510, 3515

  DOI
• PK-PD理論と臨床活用の考え方, 徳江豊, 2012, 15, 1, 41, 45
• NHCAP治療における抗菌薬の使い方 単剤, 徳江豊, 2012, 15, 3, 223, 227
• 臨床分離されたPseudomonas aeruginosaに対するarbekacinの抗菌力(2003年-2007年), 藤村茂; 五味和紀; 高根秀成; 中野禎久; 布施克浩; 菊地利明; 徳江豊; 渡辺彰, 2009, 57, 2, 91, 96
• ICDによるネットワークを軸にした地域の取り組み：群馬県, 徳江 豊, 2013, 22, 8, 772, 775
• アジスロマイシン, 徳江 豊, 2013, 1, 1, 110, 116
• 群馬大学医学部附属病院における酵母真菌の分離状況と薬剤感受性の分析, 渡邊 瑠海; 内田 梓; 高橋 美紀; 四方田 幸恵; 奈良 誠人; 荻原 貴之; 徳江 豊; 村上 正巳, 2013, 61, 1, 5-9.
• 感染症の迅速診断, 徳江 豊, 2014, 103, 11, 2701, 2707

  DOI
• Metallo-β-lactamase-producing Klebsiella pneumoniae infection in a non-hospital environment, Rumi Okazaki; Shuichi Hagiwara; Takao Kimura; Yutaka Tokue; Masahiko Kambe; Masato Murata; Makoto Aoki; Minoru Kaneko; Kiyohiro Oshima; Masami Murakami, 2016, 3, 1, 32, 35

  DOI
• Comparative in-vitro activity of carbapenem antibiotics against respiratory pathogens isolated between 1999 and 2000, A. Watanabe; Y. Tokue; H. Takahashi; T. Kikuchi; T. Kobayashi; K. Gomi; S. Fujimura; S. Yasui; Y. Murayama; T. Nukiwa, 2001, Journal of Infection and Chemotherapy, 7, 4, 267, 271

  DOI
• Charithromycin suppresses lipopolysaccharide-induced interleukin -8 production by human monocytes through AP-1 and NF-kB transcription factors, TOKUE YUTAKA; kikuchi Toru, 2002, J Antimicrob Chemother, 49: 745-755
• Mouse SWAM1 and SWAM2 are antibacterial proteins composed of a single whey acidic protein (WAP) motif, TOKUE YUTAKA; Hagiwara Koichi, 2003, J immunol, 170: 1973-1979
• Dendritic cells pulsed with live and dead Legionella pneumophila elicit distinct immune responses, TOKUE YUTAKA; Kikuchi Toshiaki, 2004, J Immunol, 172: 1727-1734
• Mannose-binding lectin gene polymorphism is a modulating factor in repeated respiratory infections, TOKUE YUTAKA; Gomi Kazunori, 2004, Chest, 126: 95-99

  DOI
• Severe acute interstitial pneumonia and gefitinib, TOKUE YUTAKA; Inoue Akira, 2003, Lancet, 361: 137-139

  DOI
• Identification of mycobacteria by nonradioisotopic single-strand conformation polymorphism analysis., TOKUE YUTAKA; Sugano Kokichi, 1995, Diagn Microbiol Infect Dis, 23: 129-133

  DOI
• Eyelid metastasis from breast cancer showing marked response to chemotherapy, TOKUE YUTAKA; Zhang GJ, 1995, Jpn J Clin Oncol, 25: 10-15
• Colonoscopy for frank bloody stools associated with cancer chemotherapy, TOKUE YUTAKA, 1997, Jpn J Clin Oncol, 27: 111-114

  DOI
• Increased levels of mitochondrial DNA in an etoposide-resistant human monocytic leukaemia cell line (THP-1/E), TOKUE YUTAKA; Saijo Yasuo, 1991, Eur J Cancer, 27: 1436-1440
• Detection of methicillin-resistant Staphylococcus aureus (MRSA) using polymerase chain reaction amplification, TOKUE YUTAKA; Shoji Satoru, 1991, Tohoku J Exp Med, 161: 31-37
• Comparison of a polymerase chain reaction assay and a conventional microbiologic method for detection of methicillin-resistant Staphylococcus aureus, TOKUE YUTAKA; Shoji Satoru, 1992, Antimicrob Agents Chemother, 36: 31-37

  DOI
• Detecting methicillin resistance in Staphylococcus aureus by polymerase chain reaction-reply, TOKUE YUTAKA, 1992, Antimicrob Agents Chemother, 36: 1585-1586
• Detection of novel mutations in the gyrA gene of Staphylococcus aureus by nonradioisotopic single-strand conformation polymorphism analysis and direct DNA sequencing., TOKUE YUTAKA; Sugano Kokichi, 1994, Antimicrob Agents Chemother, 38: 428-431

  DOI
• DNA gyrase gyrA gene mutations in ofloxacin-resistant Staphylococcus aureus, TOKUE YUTAKA; Sugano Kokichi, 1995, Int J Antimicrob Agents, 6: 129-133

  DOI
• A newly recognized acetylated metabolite of arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus, TOKUE YUTAKA; Fujimura Shigeru, 1998, J Antimicrob Chemother, 41: 495-497

  DOI
• CD44 variant isoform expression and breast cancer prognosis, TOKUE YUTAKA; Mastumura Yasuhiro, 1998, Jpn  J Cancer Res, 89: 283-290
• A Phase I Trial of Docetaxel and 5-day continuous infusion of 5-Fluorouracil in Patients with Advanced or Recurrent Breast Cancer, TOKUE YUTAKA; Ando Masashi, 1998, Br J Cancer, 77: 1937-1943
• In vitro activity of HSR-903, a new oral quinolone, against bacteria causing respiratory infections, TOKUE YUTAKA; Watanabe Akira, 1999, Antimicrob Agents Chemother, 43: 1767-1768
• In vitro antimicrobial activity and penetration rate into sputum of gatifloxacin, a novel 6-fluoro-8-methoxy quinolone, and its therapeutic efficacy in respiratory infections, Akira Watanabe; Tohru Kikuchi; Afzalunnesa Binte Lutfor; Yutaka Tokue; Hiroshi Takahashi; Shigeru Fujimura; Satoru Shoji; Yoshihiro Honda; Ytishi Nakai; Toshihiro Nukiwa, 1999, Journal of Infection and Chemotherapy, 5, 3, 149, 155

  DOI
• Comparative in vitro activity of S-4661, a new parenteral carbapenem, and other antimicrobial agents against respiratory pathogens, TOKUE YUTAKA; Watanabe Akira, 2000, Chemoterapy, 46: 184-187

  DOI
• Novel arbekacin- and amikacin-modifying enzyme of methicillin-resistant Staphylococcus aureus, TOKUE YUTAKA; Fujimura Shigeru, 2000, FEMS microbiol Lett, 190: 299-303

  DOI
• Construction and Validation of a Practical Prognostic Index for Patients With Metastatic Breast Cancer, TOKUE YUTAKA; Yamamoto Noboru, 1998, J Clin Oncol, 16: 2401-2408
• Characterization of resistance to VP-16 in human leukemic cell line, TOKUE YUTAKA; Saijo Y, 1989, Tohoku J Exp Med, 159: 299-306

  DOI
• Reduced topoisomerase 2-mediated DNA cleavage in VP-16 resistant human leukemic cell line, TOKUE YUTAKA; Saijo Yasuo, 1991, Anticancer Res, 11: 445-448
• Comparative in vitro activity of vancomycin and other antimicrobial agents against MRSA and Enterococcus faecium in Tohoku district of Japan, TOKUE YUTAKA; Lutffor AB, 1998, Chemotherapy, 44: 318-323

  DOI
• Comparative in vitro activity of carbapenem antibiotics against respiratory pathogens isolated in recent years, Akira Watanabe; Hiroaki Kikuchi; Tohru Kikuchi; Afzalunnesa Binte Lutfor; Yutaka Tokue; Hiroshi Takahashi; Shigeru Fujimura; Saforu Shoji; Yoshihiro Honda; Yushi Nakai; Toshihiro Nukiwa, 1999, Journal of Infection and Chemotherapy, 5, 3, 171, 175

  DOI
• High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein acrA, TOKUE YUTAKA; Mazzariol A, 2000, Antimicrob Agents Chemother, 44: 3441-3443

  DOI
• Tumor-associated fever in recurrent breast cancer with liver metastases, TOKUE YUTAKA; Zhang GJ, 1994, Breast Cancer, 1: 145-150
• Incidence of various gyrA mutations in 451 Staphylococcus aureus strains isolated in Japan and their susceptibilities to 10 fluoroquinolones., TOKUE YUTAKA; Takenouchi Takashi, 1995, Antimicrob Agents Chemother, 39: 1414-1418

  DOI
• Characterization of gyrA, gyrB, grlA and grlB mutations in fluoroquinolone-resistant clinical isolates of Staphylococcus aureus, TOKUE YUTAKA; Takahashi Hiroshi, 1998, J Antimicrob Chemother, 41: 49-57

  DOI
• Specificity of 4'''-acetylation by an aminoglycoside-modifying enzyme in arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus, TOKUE YUTAKA; Fujimura Shigeru, 1998, Tohoku J Exp Med, 186: 67-70

  DOI
• Association between mycobacterial genotypes and disease progression in Mycobacterium avium pulmonary infection, T. Kikuchi; A. Watanabe; K. Gomi; T. Sakakibara; K. Nishimori; H. Daito; S. Fujimura; R. Tazawa; A. Inoue; M. Ebina; Y. Tokue; M. Kaku; T. Nukiwa, 2009, Thorax, 64, 10, 901, 907

  DOI
• A Striking Increase in Seroprevalence of Measles-Specific Immunoglobulin G Among Native Japanese Healthcare Students: The Impact of a Five-Year Measles-Rubella Vaccination Catch-Up Campaign in Japan., Kimura T; Takeichi A; Inoue T; Suto C; Tsunekawa K; Nara M; Tokue Y; Murakami M, 2015, Advances in Medicine and Biology, 91, 127, 133
• Comparison of 16S ribosomal RNA gene sequence analysis and conventional culture in the environmental survey of a hospital, Manaka A; Tokue Y; Murakami M, 2017, Journal of Pharmaceutical Health Care and Sciences, 3, 8

  DOI
• Metallo-β-lactamase-producing Klebsiella pneumoniae infection in a non-hospital environment, Rumi Okazaki; Shuichi Hagiwara; Takao Kimura; Yutaka Tokue; Masahiko Kambe; Masato Murata; Makoto Aoki; Minoru Kaneko; Kiyohiro Oshima; Masami Murakami, 2016, Acute Medicine & Surgery, 3, 1, 32, 35

  DOI

Books etc

• 感染症/アレルギー/膠原病, Joint work, 20 Jul. 2019, 291, 4
• 感染症最新の治療, Joint work, 10 Feb. 2019, 281, 3, Scholarly book
• 今日の診断指針, Joint work, 25 Mar. 2020, 2079, 3, Textbook
• II. 病原菌はどのようにして耐性を獲得したか？どのくらい蔓延しているか？ ５．ニューキノロン耐性―突然変異による耐性 １）グラム陽性菌 平松啓一編集 耐性菌感染症の理論と実践、改訂第２版, 2002
• Q熱 3. 感染症. 山口徹、北原光夫編集、今日の治療指針, 2003
• ボレリア感染症（回帰熱、ライム病）今日の治療指針, 2004
• 第2項 肺炎、気道感染症 [8] 肺結核症 呼吸器研修医ノート, 2004
• 11.感染症・寄生虫 ヘモフィルス感染症 疾患別最新処方（改訂第4版, 2005
• 日常外来で遭遇する感染症診療ガイド（舟田久編）, 2006
• 感染症診療・投薬ガイド 第II部 疾患各論 III. 4類感染症, 2003
• 抗菌薬臨床ハンドブック, 2006
• 感染症治療マニュアル XVII 結核, 2002
• 呼吸器疾患、感染症、臨床病態学1, 2006
• 新感染症学（下）新時代の基礎・臨床研究（山口恵三編）, 2007
• （著書）検査からみた診断学，第64章. 内視鏡，気管支鏡 第65章. 生検，呼吸器. 内科診断学, 1994
• （著書）ユニバーサルプレコーション実践マニュアルー新しい感染予防対策ー, 1998
• （著書）II. 耐性のメカニズムと疫学 4.キノロン耐性 １）グラム陽性菌 平松啓一編集 耐性菌感染症の理論と実践, 1998
• （著書）呼吸器，呼吸器感染症. 山木戸道郎編 内科学レビュー98 最新主要文献と解説, 1998
• 感染症内科クリニカルスタンダード（前崎繁文編）, 2008
• 今日の耳鼻咽喉科頭頸部外科治療指針（第3版 森山寛、岸本誠司、小林俊光、川内秀之編）, 2008
• 呼吸器症候群（第２版 ）, 2008
• 最新抗菌薬療法マニュアル（渡辺彰編）, 2009
• 抗菌薬のかしこい使い方（渡辺彰編）, 2009
• 内科疾患の診断基準・病型分類・重症度, 2010
• カルバペネムをどう使うか？（河野茂編）, 2010
• 臨床感染症ブックレット3巻 検査や画像から感染症の原因微生物に迫る, 2011
• 新版 感染症診療実践ガイド 有効な抗菌薬の使いかたのすべて, 2011
• 感染症専門医テキスト 第1部解説編（日本感染症学会編）, 2011
• ガイドラインサポートハンドブック呼吸器感染症（河野茂編）, 2011
• 感染症診療Pro & Con, 2011
• ER・ICUで必要な注射用抗菌薬, 2013
• 臨床病態学1, 2013
• 呼吸器疾患―state of arts 感染性肺疾患, 2013

Presentations

• COVID-19流行時の感染対策　末梢静脈栄養輸液感染対策を含めて, 徳江豊, 日本病院総合診療医学会総会　ICD講習会, 20 Feb. 2020
• 末梢静脈栄養輸液によるバチルス感染原因調査, 徳江豊, 日本医療マネジメント学会, 16 Jan. 2020
• 大学病院の感染症医が調剤薬局薬剤師に期待すること, 徳江豊, 23 Oct. 2020, Japan
• 群馬大学医学部附属病院における抗菌薬使用と緑膿菌分離の現状, 第52回日本臨床検査医学会, 2005
• シンポジウム1 市中呼吸器感染症-その実態と治療戦略- 2）成人市中呼吸器感染症の現状と対策, 第54回日本感染症学会東日本地方総会、第52回日本化学療法学会東日本支部総会合同学会, 2005
• シンポジウム 呼吸器感染症における耐性菌抑制プログラムについて サイクリング療法によって耐性菌抑制は可能か, 第45回日本呼吸器学会学術講演会, 2005
• シンポジウム 市中呼吸器感染症における今後の治療戦略 市中呼吸器感染症の診断と治療の実際, 第46回日本呼吸器学会学術講演会, 2006
• Relevance of mannose-binding lectin (MBL) polymorphism in repeated respiratory infections, 11th ERS Annual Congress, 2001
• シンポジウム 抗菌薬臨床試験における課題と挑戦 臨床医の立場から, 第53回日本感染症学会東日本地方総会、第51回日本化学療法学会東日本支部総会 合同学会, 2004
• 群馬大学医学部附属病院における抗菌薬の使用制限と緑膿菌分離の現状, 第54回日本感染症学会東日本地方会, 2005
• Prevention and control of nosocomial respiratory infection, East asian conference on infection control and prevention, 2004
• 呼吸器感染症と遺伝子多型 ゲノム情報と感染症, 平成14年度新潟医学会総会, 2002
• シンポジウム 成人呼吸器感染症に対するレスピラトリーキノロンの位置付けー成人市中肺炎診療における適応と使い方, 第44回日本呼吸器学会総会, 2004
• シンポジウム 耐性菌の臨床ー耐性菌はどうすれば抑え込めるか？ サイクリング/ローテーションは耐性菌を抑制できるか, 第52回日本化学療法学会, 2004
• シンポジウム 呼吸器感染症と初期免疫関連遺伝子多型, 第42回日本呼吸器学会総会, 2002
• 感染制御の観点からみた検査部の果たすべき役割とその意義, 第53回日本臨床検査医学会学術集会, 2006
• 結核症の細菌検査診断と感染管理, 第24回日本臨床化学会夏期セミナー, 2005
• シンポジウム 院内肺炎診療の新しい考え方 -ATSのガイドラインと本邦における考え方- 2. 細菌性肺炎の診断と治療, 第38回日本呼吸器学会学術講演会, 1998
• シンポジウム職種連携ー病院感染対策におけるICDの役割, 日本環境感染学会, 2009
• Identification of Mycobacteria by Non-radioisotopic single-strand comformation polymorphism analysis., 7th International Congress for Infectious  Diseases, 1996
• NICU病院感染予防のためのガイドライン ガイドラインの検証, 日本環境感染学会, 2010
• 抗菌薬の適正使用を含めた病院感染対策, 日本環境感染学会, 2010
• シンポジウム抗菌薬を投与しても改善しない！抗菌薬とホスト因子 感染症におけるホスト因子の役割, 日本化学療法学会, 2010
• Detection of gyrA mutations in Staphylococcus aureus by Nonradioisotopic Single-Strand Conformation Polymorphism (Non-RI SSCP) Analysis, 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1994
• Prevalence of Q fever in Japan among patients with community acquired respiratory infection, ATS/ALA 2000 International Conference, 2000
• High frequent heterozygous and monozygous mutation in codon 54 of mannose-binding lectin gene exists among patients with repeated respiratory infection in Japan, ALA/ATS International Conference, 1999
• Retrospective survey of Q fever in Japan among patients with community acquired respiratory infection, ALA/ATS International Conference, 1999
• Retrospective survey of Q fever in Japan using PCR to detect Coxiella Burnetii DNA in broncho alveolar lavage fruids, ALA/ATS International Conference, 1998
• A newly recognized 4'''-aminoglycoside acetyltransferase in arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus, 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1998
• Construction and validation of a practical prognostic index for patients with metastatic breast cancer, 33rd Proc Am Soc Clin Oncol, 1997
• 抗菌薬の適正使用を含めた病院感染対策, 日本感染症学会西日本地方会学術集会, 2007
• 抗菌薬の適正使用, 第1回東北感染制御ネットワークフォーラム, 2008
• 日和見感染菌C.violaceumのQuorum sensingシステムと宿主免疫との関わり, 第44回日本呼吸器学会総会, 2004
• 細菌性肺炎におけるbiapenem持続点滴投与法の検討, 日本化学療法学会総会, 2009
• 肺アスペルギルス症に対するvorikonazoleの効果, 第47回日本呼吸器学会総会, 2007
• 肺アスペルギルス症に対するvorikonazoleの効果, 第46回日本呼吸器学会総会, 2006
• Ｑ熱肺炎症例におけるBAL所見に関する検討, 第45回日本呼吸器学会総会, 2005
• 群馬大学医学部附属病院における抗菌薬使用とMRSA、緑膿菌分離の現状, 第55回日本化学療法学会総会, 2007
• 一般市中病・医院におけるmetallo-beta-lactamase産生緑膿菌の分離頻度と薬剤感受性, 第52回日本化学療法学会総会, 2004
• 2003年分離の呼吸器病原細菌に対するカルバペネム4薬剤の抗菌力, 第52回日本化学療法学会総会, 2004
• VCM、TEIC、ABK が無効でLinezolidにより救命し得たMRSA敗血症の1例, 第52回日本化学療法学会総会, 2004
• 2003年度に東北地方で分離された緑膿菌の疫学調査成績, 第52回日本化学療法学会, 2004
• 急性Ｑ熱における複雑菌感染呼吸器感染症例の検討, 第52回日本化学療法学会総会, 2004
• 群馬大学医学部新入生、群馬大学医学部附属病院新入職研修医の風疹、麻疹、ムンプス、水痘抗体保有率, 第61回日本感染症学会東日本地方会学術集会、第59回日本化学療法学会東日本支部総会合同学会, 2012
• 群馬県内での院内感染対策支援調査（相互チェック）の取り組み, 第27回日本環境感染学会総会, 2012
• Acinetobacter baumanniiの創部感染事例から浴室環境管理を見直した取り組み, 第28回日本環境感染学会総会, 2013
• Tuberculosis screening by a T cell interferon-γ release assay in students of medical school and international students in Gunma University., The12th meeting of the Asian Society of Clinical Pathology and Laboratory Medicine, 2012
• 群馬大学医学部新入生と群馬大学留学生のクオンティフェロン陽性率の比較, 第58回日本臨床検査医学会学術集会, 2011
• 当院における酵母真菌の検出状況, 第58回日本臨床検査医学会学術集会, 2011
• 群馬大学医学部附属病院研修医、医学部群馬大学医学部新入生と群馬大学留学生のクオンティフェロン陽性率の比較, 第60回日本感染症学会東日本地方会学術集会、第58回日本化学療法学会東日本支部総会合同学会, 2011
• 病院感染対策の実際 アウトブレイクへの対応, 日本呼吸器学会東北地方会, 2011
• ニューキノロン系抗菌薬の使い分け, 第60回日本感染症学会東日本地方会、第58回日本化学療法学会東日本支部総会合同学会, 2011
• Meet the Expert 「緑膿菌感染症」, 第60回日本化学療法学会, 2012
• 肺炎の診断と抗菌化学療法, 第21回日本集中治療学会関東甲信越地方会, 2012
• シンポジウム「めざせ感染症専門医 地域における感染症専門医の役割」, 第86回日本感染症学会, 2012
• 呼吸器感染症の治療～レスピラトリーキノロンを中心に～, 日本薬学会第132年会, 2012
• Relevance of mannose-binding lectin (MBL) polymorphism in repeated respiratory infections, 11th ERS Annual Congress, 2001
• Prevention and control of nosocomial respiratory infection, East asian conference on infection control and prevention, 2004
• Identification of Mycobacteria by Non-radioisotopic single-strand comformation polymorphism analysis., 7th International Congress for Infectious  Diseases, 1996
• Detection of gyrA mutations in Staphylococcus aureus by Nonradioisotopic Single-Strand Conformation Polymorphism (Non-RI SSCP) Analysis, 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1994
• Prevalence of Q fever in Japan among patients with community acquired respiratory infection, ATS/ALA 2000 International Conference, 2000
• High frequent heterozygous and monozygous mutation in codon 54 of mannose-binding lectin gene exists among patients with repeated respiratory infection in Japan, ALA/ATS International Conference, 1999
• Retrospective survey of Q fever in Japan among patients with community acquired respiratory infection, ALA/ATS International Conference, 1999
• Retrospective survey of Q fever in Japan using PCR to detect Coxiella Burnetii DNA in broncho alveolar lavage fruids, ALA/ATS International Conference, 1998
• A newly recognized 4'''-aminoglycoside acetyltransferase in arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus, 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1998
• Construction and validation of a practical prognostic index for patients with metastatic breast cancer, 33rd Proc Am Soc Clin Oncol, 1997
• Tuberculosis screening by a T cell interferon-γ release assay in students of medical school and international students in Gunma University., The12th meeting of the Asian Society of Clinical Pathology and Laboratory Medicine, 2012

Educational Activities

Awards

• 13 Feb. 2021

Social Contribution

Media Coverage

• Other than myself, 23 Mar. 2020, Internet
• Other than myself, 13 Mar. 2020, Paper
• Other than myself, 03 Apr. 2020, Paper
• Other than myself, 10 Jun. 2020, Paper
• Other than myself, 21 Nov. 2020, Paper
• Other than myself, 06 Aug. 2020, Paper